# Chapter 85: Female Orgasmic Disorder

## The Biological and Neurological Basis of Female Orgasmic Disorder

### Introduction

Female Orgasmic Disorder (FOD) is a prevalent and often distressing condition characterized by a significant delay in, infrequency of, or absence of orgasm, or markedly reduced intensity of orgasmic sensations, despite adequate sexual stimulation (Delcea, 2019; McCabe et al., 2019; Rowland & Incrocci, 2008). For a diagnosis to be made, these symptoms must cause clinically significant personal distress (Unknown, 2019; Meston et al., 2023). Epidemiological data suggest that orgasmic problems are common, with some studies indicating a worldwide prevalence of FOD as high as 42% (Delcea, 2019), and a broader prevalence of female sexual dysfunction (FSD) ranging from 20% to 40% (Brubaker & Guntupalli, 2020). The disorder can manifest as a lifelong condition, present from the onset of sexual activity, or as an acquired disorder that develops after a period of normal sexual function (Delcea, 2019). Furthermore, its presentation can be generalized across all situations or be situational, occurring only with certain types of stimulation or partners (Delcea, 2019).

The experience of orgasm represents the apex of the sexual response cycle, a transient peak of intense physical and psychological pleasure that facilitates the release of sexual tension (McCabe et al., 2019; Meston et al., 2004). The inability to consistently achieve this state can lead to significant frustration, emotional anguish, and feelings of inadequacy, profoundly impacting a woman's quality of life, self-esteem, and interpersonal relationships (Stuparu, 2020; McCabe et al., 2019; Giraldi, 2024). Despite its prevalence, FOD is often underreported and underdiagnosed, partly due to patient embarrassment and a lack of adequate knowledge or comfort among healthcare providers in addressing sexual health concerns (Unknown, 2019).

The etiology of FOD is recognized as complex and multifactorial, involving an intricate interplay of biological, psychological, and sociocultural factors (Snyder et al., 2016; Giraldi, 2024). While psychosocial elements—such as relationship conflicts, performance anxiety, history of sexual trauma, and restrictive cultural or religious attitudes—are critical components in the development and maintenance of FOD (McCabe et al., 2019; Stuparu, 2020), this chapter will focus specifically on the biological and neurological mechanisms that form the substrate for this disorder. Understanding these foundational processes is essential for developing a comprehensive etiologic model and for designing targeted and effective interventions. This chapter will synthesize the available evidence on the roles of neurotransmitter systems, neuroendocrine regulation, brain structure and function, genetic predispositions, and the impact of comorbid neurological and medical conditions on the female orgasmic response. By elucidating the neurobiological architecture of female orgasm, we can better comprehend the diverse pathways that can lead to its disruption.

### Neurobiological Systems

The female orgasmic response is a complex neurophysiological event orchestrated by a network of central and peripheral systems. Dysfunction in any component of this network can contribute to the development of FOD. Key systems implicated include neurotransmitter pathways, the neuroendocrine axis, and peripheral and central neural circuits that process sensory information and mediate motor and autonomic responses.

#### Neurotransmitter Systems and Neuropharmacology

The balance of excitatory and inhibitory neurotransmitters in the central nervous system is critical for sexual function, including orgasm (Sonavane et al., 2023). An imbalance in these systems, whether due to an underlying psychiatric condition or the effects of medication, is a primary contributor to orgasmic difficulties (Feldman & Larsen, 2014).

**The Serotonergic System:** The serotonergic system is arguably the most extensively implicated neurotransmitter system in the modulation of orgasm. A wealth of clinical evidence demonstrates that medications which increase synaptic serotonin, particularly Selective Serotonin Reuptake Inhibitors (SSRIs), are strongly associated with sexual side effects, including delayed orgasm, anorgasmia, and diminished orgasmic intensity (Sonavane et al., 2023; Higgins, 2010; Rosen et al., 1999; Montejo et al., 2015). The incidence of SSRI-induced sexual dysfunction is high, with some reports suggesting it affects over 50-70% of patients (Backlund et al., 2005; Atmaca, 2020; Montejo et al., 2018). This inhibitory effect is not limited to SSRIs; other serotonergic antidepressants like clomipramine also produce significant orgasmic dysfunction (Sobański et al., 2012; King & Nepps, 1993). The effects of SSRIs appear to be dose-related (Rosen et al., 1999), and the underlying mechanisms are multifaceted, potentially involving actions at various serotonin receptor subtypes (Hyun, 2014).

While high overall serotonergic tone appears to be inhibitory, the role of specific receptors is more nuanced. For instance, research into drug-associated spontaneous orgasm (DASO) suggests that augmentation of serotonin-1A (5-HT1A) neurotransmission may play a key role in *generating* orgasm (Chen et al., 2017). This finding complicates a simple inhibitory model and suggests that orgasm may depend on the activation of specific serotonergic pathways (e.g., via 5-HT1A receptors) against a background of generalized serotonergic inhibition mediated by other receptors, such as 5-HT2C (Hyun, 2014; Chen et al., 2017). Some atypical antipsychotics, such as aripiprazole, which act as partial agonists at 5-HT1A receptors, have been associated with fewer sexual side effects and may even mitigate hyperprolactinemia, further highlighting the complex role of this receptor (Abassi et al., 2024; Ribeirinho Soares et al., 2023).

**The Dopaminergic System:** Dopamine is fundamentally involved in motivation, pleasure, and reward circuits in the brain (Calderón, 2021; Insel, 2002). Consequently, dysfunction in dopaminergic pathways can impair sexual function. This is most evident in the context of antipsychotic medications, which primarily act by blocking D2 dopamine receptors (Cubała, 2006). This D2 blockade is a major mechanism behind antipsychotic-induced sexual dysfunction, including decreased libido and anorgasmia (La Torre et al., 2013; Montejo et al., 2018; Maguire, 2002). The negative impact of D2 blockade is further compounded by the subsequent elevation of prolactin, a hormone that also suppresses sexual function (Maguire, 2002). Conversely, medications that enhance dopamine activity, such as bupropion, are associated with a lower risk of sexual side effects and are sometimes used as a strategy to counteract SSRI-induced anorgasmia (Kanaly & Berman, 2002; Florian Tran et al., 2025). The critical role of dopamine is also suggested by the high prevalence of sexual dysfunction in Parkinson's disease, a neurodegenerative condition characterized by dopamine deficiency (Bronner et al., 2004).

**The Noradrenergic System:** Norepinephrine is also involved in sexual response, particularly through its role in the autonomic nervous system. Some psychotropic drugs that cause noradrenergic blockade have been associated with disturbances in ejaculation and, by extension, may affect female orgasm and lubrication (Cubała, 2006). Conversely, antidepressants that enhance noradrenergic activity, such as mirtazapine and bupropion, generally have a more favorable sexual side effect profile compared to SSRIs (Florian Tran et al., 2025; Farah, 1999).

**Other Neurotransmitters:** The GABAergic system, the primary inhibitory system in the brain, also plays a role. Progesterone metabolites have been shown to interact with the GABA-A receptor, providing a link between hormonal fluctuations and central nervous system inhibition (Bäckström & Hammarbäck, 1991; Rapkin et al., 2019). This may be relevant to cyclical changes in sexual function and mood. Furthermore, nitric oxide is a key peripheral mediator of vasocongestion, a critical component of sexual arousal; some research suggests that SSRIs may inhibit nitric oxide synthetase, contributing to arousal difficulties that can secondarily impact orgasm (Rosen et al., 1999).

#### Neuroendocrinology and Hormonal Influences

The endocrine system, through a complex interplay of hormones, directly and indirectly regulates all aspects of human sexual function, including desire, arousal, and orgasm (Balercia et al., 2007). Hormonal fluctuations and deficiencies are therefore significant biological contributors to FOD.

**The Hypothalamic-Pituitary-Gonadal (HPG) Axis:** The HPG axis is the central regulatory pathway for reproductive and sexual hormones. Its function can be disrupted by numerous factors, including chronic stress, neurological disease, and medication (Meyer & Hamel, 2014; Morrell, 1991). In women with epilepsy, for example, epileptiform discharges in limbic areas can alter the release of hypothalamic or pituitary hormones, leading to sexual dysfunction (Morrell, 1991; Herzog, 1982). Similarly, chronic stress can lead to hypothalamic amenorrhea, a state of suppressed reproductive function that impacts sexual health (Genazzani et al., 2006).

**Sex Steroids:** Estrogens, progestogens, and androgens are the primary hormonal modulators of female sexual response. Their levels fluctuate significantly across the menstrual cycle and the lifespan, particularly during perimenopause and menopause, which are periods of increased vulnerability for both mood and sexual disorders (Duval et al., 2010; Scavello et al., 2019).
*   **Estrogens:** Estrogen is crucial for maintaining the health of genital tissues, promoting vaginal lubrication and elasticity (Hauser, 1990). The decline in estrogen during menopause leads to genitourinary syndrome of menopause (GSM), characterized by vaginal atrophy and dryness, which can cause dyspareunia and secondarily inhibit arousal and orgasm (Scavello et al., 2019; Veeninga & Kraaimaat, 1995). Estrogens also have central effects, modulating neurotransmitter systems like serotonin, which indirectly impacts mood and sexual function (Clayton, 2002; Arató, 1995).
*   **Progesterone:** Progesterone and its neuroactive metabolites, such as allopregnanolone, can have sedative and anxiolytic effects through their action on GABA-A receptors (Bäckström & Hammarbäck, 1991). In some women, an enhanced sensitivity to progesterone during the luteal phase is thought to be a key factor in the pathophysiology of Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD), conditions characterized by mood lability, irritability, and sometimes changes in sexual desire and response (Usman et al., 2007; Rapkin et al., 2019).
*   **Androgens:** Testosterone plays a significant role in female sexual desire (libido), and its decline with age may contribute to hypoactive sexual desire disorder (HSDD) (Buster, 2018; Seidman, 2003). While primarily associated with desire, low androgen levels may also impact arousal and orgasmic capacity, as a sufficient level of desire is often a prerequisite for a full sexual response (Clayton, 2002). Studies in men link hypogonadism directly to ejaculatory and orgasmic problems, suggesting a parallel role for androgens in female orgasm (Corona et al., 2006; Janmohamed & Bouloux, 2016).

**Prolactin:** Prolactin is a hormone primarily known for its role in lactation, but it also has a potent inhibitory effect on sexual function. Hyperprolactinemia (elevated prolactin levels) is a well-established cause of decreased libido, anorgasmia, and menstrual irregularities (Maguire, 2002; Balercia et al., 2007). It is a common side effect of D2-blocking antipsychotic medications (e.g., risperidone, haloperidol) and can also be associated with certain neurological conditions like temporal lobe epilepsy (Carvalho & Góis, 2011; Herzog, 1982). Prolactin exerts its effects by suppressing the HPG axis, leading to secondary hypogonadism, and may also have direct inhibitory effects within the central nervous system (Maguire, 2002).

**Other Hormones:** The stress hormone cortisol, released via the hypothalamic-pituitary-adrenal (HPA) axis, can also influence sexual function. Chronic stress and elevated cortisol levels are associated with depression and anxiety, which are strongly linked to sexual dysfunction (Hellhammer & Wade, 1993; Leitão et al., 2024). Thyroid dysfunction (both hyper- and hypothyroidism) can also impact sexual response, although the mechanisms are less clearly defined (Balercia et al., 2007; Hallengren, 1998).

### Genetic and Molecular Basis

The role of genetics in Female Orgasmic Disorder is an emerging area of research, and the existing literature does not yet provide direct evidence from large-scale genomic studies specifically targeting FOD. However, a genetic contribution can be inferred from the high comorbidity of FOD with other neuropsychiatric and neurological conditions that have a known heritable component (Feldman & Larsen, 2014).

#### Heritability of Comorbid Conditions

A substantial body of evidence supports the heritability of disorders frequently co-occurring with FOD. Major Depressive Disorder (MDD) and other affective illnesses show strong familial patterns and genetic influence (Coppen & Swade, 1988; Cadoret & Winokur, 1972). Given that depression is one of the most significant risk factors for sexual dysfunction, including anorgasmia (Feldman & Larsen, 2014; Basson & Gilks, 2018; Yagubov et al., 2024), it is plausible that genetic variants predisposing an individual to depression also indirectly increase their vulnerability to FOD. Similarly, anxiety disorders, which are associated with difficulties in achieving pleasure and orgasm (Basson & Gilks, 2018; Piggott et al., 2019), also have a heritable component (Piggott et al., 2019).

Neurological conditions such as epilepsy and schizophrenia, both of which are linked to high rates of sexual dysfunction, also have significant genetic underpinnings (Beghi & Beghi, 2013; Arnold, 1999). In schizophrenia, for instance, genetic factors contribute to the neurodevelopmental abnormalities and neurotransmitter dysregulation that underlie both the primary illness and its associated impairments in sexual function (Arnold, 1999; Buckley & Foster, 2014). Therefore, shared genetic pathways may contribute to a common vulnerability for both a primary psychiatric/neurological disorder and a secondary sexual dysfunction like FOD. The observation that disorders like ADHD and Autism Spectrum Disorder (ASD), which have strong genetic links, are associated with altered sensory processing and social-emotional difficulties suggests that genetic factors influencing neurodevelopment could fundamentally shape an individual's psychosexual function from an early age (Güney & İşeri, 2013; Agnew‐Blais & Seidman, 2013).

#### Molecular Mechanisms

At the molecular level, genetic variability can influence the neurobiological systems that mediate orgasm. One clear example is in pharmacogenetics. Genetic polymorphisms in the cytochrome P450 (CYP450) enzyme system, particularly CYP2D6, are known to alter the metabolism of many SSRIs (Bostankolu et al., 2014; Winner, 2012). Individuals who are "poor metabolizers" due to their genetic makeup may experience higher drug concentrations and, consequently, more severe side effects, including anorgasmia (Winner, 2012). This demonstrates a direct link between an individual's genetic profile and their susceptibility to medication-induced FOD.

Furthermore, genes that code for receptors, transporters, and enzymes within the serotonergic and dopaminergic systems are logical candidates for influencing orgasmic capacity. While not directly studied in FOD in the provided literature, variations in these genes could theoretically lead to baseline differences in neurotransmitter tone or receptor sensitivity, predisposing some individuals to difficulties with orgasm. Similarly, genetic factors influencing the synthesis, transport, and receptor sensitivity of sex hormones could create a biological predisposition to sexual dysfunction (Lin et al., 2007). For example, genetic disorders affecting adrenal development and hormone production can lead to primary adrenal insufficiency, which has neuropsychiatric consequences (Lin et al., 2007; Rose & Weinstein, 1936). While speculative, it is conceivable that subtle genetic variations in these same hormonal pathways could contribute to the heterogeneity of orgasmic function in the general population.

In summary, while direct genetic markers for FOD have not been identified in the reviewed literature, there is strong indirect evidence for a genetic contribution. This contribution is likely mediated through inherited vulnerabilities to comorbid psychiatric and neurological disorders, as well as through individual differences in neurochemistry and hormone regulation that form the biological foundation of sexual response.

### Brain Structure and Function

The ability to achieve orgasm is not a peripheral genital reflex but a complex brain-mediated event involving the integration of sensory, cognitive, emotional, and autonomic processes. Neurological disorders and structural brain abnormalities provide critical insights into the central nervous system architecture underlying orgasmic function and its disruption in FOD.

#### Brain Regions and Neural Circuits

Evidence from a range of clinical conditions points to several key brain regions and circuits as being integral to sexual function and orgasm.

**The Limbic System and Temporal Lobes:** The limbic system, which includes structures like the amygdala, hippocampus, and cingulate gyrus, is the brain's primary center for emotion, motivation, and memory (Pontius, 1993). Its intimate connection with sexual function is well-established. Temporal Lobe Epilepsy (TLE), which often involves seizures originating in or spreading to limbic structures, is associated with a particularly high rate of sexual dysfunction, including orgasmic difficulties (Morrell, 1991; Broglin, 2009). Epileptiform discharges within the temporal lobes can disrupt the normal function of these structures, leading to altered hormonal regulation via the hypothalamus and direct interference with the neural processing of sexual arousal and pleasure (Herzog, 1982; Morrell, 1991). Strikingly, some case studies have documented orgasm-induced seizures, often with an epileptogenic focus in the right temporal lobe, providing a direct, albeit rare, link between the neurophysiology of orgasm and this brain region (Özkara et al., 2006). Furthermore, brain injuries affecting limbic structures have been shown to cause profound changes in sexual preference and behavior, reinforcing the role of this system in organizing complex sexual responses (Miller et al., 1986). The Klüver-Bucy syndrome, which can include hypersexuality, is a classic result of bilateral temporal lobe lesions (Berner, 1971).

**The Frontal Lobes:** The frontal lobes, particularly the prefrontal cortex, are responsible for executive functions such as judgment, impulse control, social behavior, and the integration of emotion with cognition (Pontius, 1988). Dysfunction in this region can lead to disinhibition and inappropriate sexual behaviors (Miller et al., 1986; Wick & Zanni, 2005). While often associated with hypersexuality, this disinhibition highlights the frontal lobe's crucial role in the top-down regulation of sexual urges and responses. One hypothesis suggests that antidepressants causing sexual dysfunction may do so by activating left-hemisphere frontal structures at the expense of right-hemisphere systems that are more dominant in controlling emotional and sexual activity (Rotenberg, 2010). A functional imbalance between frontal lobe regulatory systems and limbic system drives may therefore contribute to sexual dysfunction (Pontius, 1984).

**Hypothalamus and Diencephalon:** The hypothalamus is a critical node linking the central nervous system with the endocrine system via the pituitary gland. It is the master regulator of the HPG axis and plays a vital role in autonomic function (Palmer, 1999; Balercia et al., 2007). Lesions or dysfunction in this area, as seen in some brain injuries or in disorders like Kleine-Levin syndrome (which can feature hypersexuality), disrupt both hormonal balance and fundamental drives, including sexual behavior (Miller et al., 1986; Unknown, 2019).

**Brainstem and Spinal Cord:** The brainstem and spinal cord contain the essential autonomic and somatic pathways that mediate the peripheral components of sexual response, such as genital vasocongestion and pelvic muscle contractions (Kessler et al., 2009). Neurological conditions that damage these pathways, such as Multiple Sclerosis (MS) and Cauda Equina Syndrome (CES), are frequently associated with severe orgasmic dysfunction (Kessler et al., 2009; Scheiber-Nogueira, 2009). In MS, demyelinating lesions in the spinal cord can interrupt the ascending sensory pathways that convey genital stimulation to the brain and the descending motor pathways that trigger the muscular contractions of orgasm (Bronner et al., 2010). Similarly, compression of the nerve roots in CES can lead to a profound loss of genital sensation and an inability to achieve orgasm (Scheiber-Nogueira, 2009). The pudendal nerve is a key peripheral nerve, and its entrapment or dysfunction can cause genital pain and sexual dysfunction (Lema & Ricci, 2006).

#### Neuroimaging Findings

The provided research literature does not contain direct functional or structural neuroimaging studies (e.g., fMRI, PET) conducted on women with a primary diagnosis of FOD. This represents a significant gap in the field. However, findings from neuroimaging of comorbid conditions offer valuable indirect evidence.

Structural imaging in patients with neurological disorders associated with FOD reveals the anatomical basis of the dysfunction. For example, MRI scans in patients with MS show demyelinating plaques in the brain and spinal cord, and the location and burden of these lesions can correlate with the presence of sexual symptoms (Kessler et al., 2009). In stroke patients, the location of the infarct can predict the type of subsequent sexual dysfunction (Mahdy et al., 2018).

Functional imaging studies in related areas, such as sexual addiction, have demonstrated alterations in brain pathways involved in reward, motivation, and cognitive control (Calderón, 2021). It is plausible that women with FOD may exhibit converse patterns, such as hypoactivation in reward circuits (e.g., the nucleus accumbens) or hyperactivation in inhibitory regions (e.g., prefrontal cortex) in response to erotic stimuli. Furthermore, neuroimaging in depression reveals structural and functional changes in the limbic system and prefrontal cortex (Dreyer-Oren et al., 2018), regions that are also central to sexual response. Future neuroimaging research specifically targeting women with FOD is critical to directly map the neural circuits of orgasmic inhibition and failure.

### Developmental Neurobiology

Female Orgasmic Disorder, like many psychiatric conditions, can be conceptualized through a neurodevelopmental lens, where early life experiences and developmental stages interact with biological predispositions to shape adult function (Rothenberger & Hüther, 1997). The disorder may be present from the beginning of sexual life (lifelong) or emerge after a period of normal function (acquired), suggesting different developmental trajectories and etiological factors (Delcea, 2019).

#### Critical Periods and Hormonal Transitions

Adolescence is a critical period for psychosexual development, marked by the onset of puberty and the activation of the HPG axis (Steinberg, 1987). This period involves significant hormonal changes that organize and activate neural circuits related to sexuality (Golubtsova et al., 1988). It is also a time of heightened vulnerability to the onset of psychiatric disorders such as depression, anxiety, and schizophrenia, many of which have their peak incidence in late adolescence or early adulthood (Kessler et al., 2007; Arnold, 1999). The emergence of a mental disorder during this formative period can profoundly disrupt normal psychosexual development, potentially leading to long-term sexual dysfunction, including FOD (Golubtsova et al., 1988; Crisp & Toms, 1972).

Other periods of significant hormonal fluctuation across a woman's lifespan, such as the postpartum period and the menopausal transition, also represent windows of vulnerability (Duval et al., 2010; Clayton, 2002). Postpartum depression is a common complication of childbirth, and is strongly associated with sexual problems, including difficulty with orgasm (Cuijpers, 2010; Jadresic, 2017). The perimenopause is characterized by erratic hormonal changes and is associated with an increased risk for new-onset or recurrent depressive episodes, anxiety, and sleep disturbances, all of which negatively impact sexual function (Rasgon et al., 2005; Carvajal-Lohr et al., 2016; Scavello et al., 2019). The biological changes of these periods, combined with psychosocial stressors, can unmask or precipitate FOD in susceptible individuals (Duval et al., 2010).

#### The Role of Early Life Adversity and Trauma

A substantial body of evidence indicates that adverse childhood experiences, including physical, emotional, and sexual abuse, are potent risk factors for a wide range of adult psychiatric and somatic disorders (Meyer & Hamel, 2014; Verma & Agrawal, 2021; Bouras & Lazaratou, 2012). Stressful or traumatic events in childhood can have lasting effects on the structural and functional development of the brain, particularly on stress-response systems like the HPA axis and on neural circuits involved in emotion regulation, such as the prefrontal-limbic pathways (Rothenberger & Hüther, 1997).

This neurobiological "scarring" from early trauma creates a diathesis for later psychopathology. Individuals with a history of childhood abuse have significantly higher rates of depression, anxiety disorders, post-traumatic stress disorder (PTSD), and personality disorders in adulthood (Verma & Agrawal, 2021; Ghogare et al., 2021; Drossman, 1997). These disorders, in turn, are strongly and bidirectionally linked with sexual dysfunction (Basson & Gilks, 2018; Meltzer‐Brody & Leserman, 2011). A history of sexual abuse is a particularly powerful predictor of subsequent sexual difficulties, including orgasmic problems, dyspareunia, and low desire (Meltzer‐Brody & Leserman, 2011; Golding, 1999; Moscarello, 1991). The trauma may lead to a fundamental disruption in the ability to experience trust, intimacy, and pleasure, which is encoded at a neurobiological level and manifests as a persistent barrier to orgasm (Basson & Gilks, 2018). Dissociative symptoms, a common sequela of trauma, can also interfere with the ability to remain present and engaged during sexual activity, a prerequisite for orgasm (van der Hart et al., 2013). Therefore, the neurodevelopmental impact of early trauma represents a crucial biological pathway to the development of FOD.

### Treatment Mechanisms

Understanding the biological basis of FOD provides a rationale for various treatment strategies that aim to modulate the underlying neurophysiological and neurochemical systems. While no pharmacological treatment is specifically approved for FOD (Giraldi, 2024), several approaches target the biological factors contributing to the disorder, often by treating comorbid conditions or offsetting medication side effects.

#### Neuropharmacological Interventions

Given the high prevalence of antidepressant-induced FOD, a primary management strategy involves modifying the patient's pharmacotherapy to reduce serotonergic inhibition (Higgins, 2010; Sonavane et al., 2023). The biological mechanism of these strategies is to restore a more favorable balance of neurotransmitters, particularly serotonin and dopamine.
*   **Dose Reduction and "Drug Holidays":** Lowering the dose of an SSRI can sometimes alleviate sexual side effects while maintaining antidepressant efficacy (Kanaly & Berman, 2002). This works by reducing the overall serotonergic load on receptors involved in orgasm inhibition. Similarly, "drug holidays" (e.g., skipping medication for 1-2 days prior to anticipated sexual activity) have been proposed, though this strategy carries a risk of withdrawal symptoms or relapse of depression (Kanaly & Berman, 2002).
*   **Switching Antidepressants:** A common and often effective strategy is to switch from a high-serotonin agent to one with a different neurochemical profile (Florian Tran et al., 2025). Antidepressants like bupropion (a norepinephrine-dopamine reuptake inhibitor), mirtazapine (a noradrenergic and specific serotonergic antidepressant), and nefazodone have a much lower incidence of sexual dysfunction (Montejo et al., 2015; Farah, 1999; Sobański et al., 2012). The mechanism involves moving away from potent serotonin reuptake inhibition and engaging dopaminergic and noradrenergic pathways that are more facilitatory to sexual response (Rotenberg, 2010).
*   **Augmentation Strategies:** Another approach is to add a second medication to counteract the side effects of the primary antidepressant. Bupropion is frequently used as an augmenting agent, presumably by boosting dopamine levels to overcome serotonergic inhibition (Florian Tran et al., 2025). Other agents, such as dopaminergic agonists, have also been suggested to work through a similar mechanism of enhancing pro-sexual neurotransmitter activity (Martin-Du & Baumann, 2008).

#### Neuroendocrine and Hormonal Treatments

For women whose orgasmic difficulties are linked to hormonal changes, particularly during menopause, hormone therapy can be an effective intervention.
*   **Estrogen Therapy:** For postmenopausal women experiencing dyspareunia due to GSM, local vaginal estrogen therapy can restore tissue health, improve lubrication, and reduce pain during intercourse (Scavello et al., 2019). By alleviating pain, a major inhibitor of arousal and orgasm, this treatment can secondarily improve orgasmic function (Veeninga & Kraaimaat, 1995). Systemic estrogen may also have central effects on mood and well-being that contribute to improved sexuality (Hauser, 1990).
*   **Testosterone Therapy:** In postmenopausal women with distressing low sexual desire, off-label use of testosterone has been shown to improve libido and may also enhance arousal and orgasmic response (Buster, 2018; Clayton, 2002). The mechanism is thought to involve both central effects on motivation and reward circuits and peripheral effects on genital tissues (Janmohamed & Bouloux, 2016).

#### Neurological and Psychotherapeutic Interventions

For FOD secondary to neurological conditions, treatment of the primary disorder is paramount. In epilepsy, optimizing antiepileptic drug (AED) choice to minimize side effects on the HPG axis or switching away from enzyme-inducing AEDs can be beneficial (Morrell, 1991; Cubała, 2006).

While psychotherapy is not a biological treatment, its effects are ultimately mediated by changes in the brain. Cognitive Behavioral Therapy (CBT), for example, is effective for comorbid depression and anxiety (Fava et al., 2002; Mandos et al., 2009). The neurobiological mechanism of CBT is thought to involve neuroplastic changes that strengthen top-down regulation from the prefrontal cortex over hyperactive limbic structures (e.g., the amygdala) (Feldman & Larsen, 2014). By reducing anxiety, catastrophizing thoughts, and attentional focus on negative stimuli, CBT may free up the cognitive and emotional resources necessary for sexual arousal and orgasm to occur, effectively altering the brain's functional state during sexual activity.

### Future Directions

Despite significant progress in understanding the multifaceted nature of female sexual response, the specific biological and neurological underpinnings of Female Orgasmic Disorder remain incompletely understood. The available literature, while providing numerous associative links and plausible mechanisms, highlights several critical gaps and points toward necessary avenues for future research.

First, there is a pressing need for dedicated, large-scale genetic studies, such as genome-wide association studies (GWAS), specifically in populations of women with lifelong and acquired FOD. While we can infer a genetic contribution from the heritability of comorbid disorders like depression and anxiety (Coppen & Swade, 1988; Piggott et al., 2019), identifying specific genes and polymorphisms directly associated with orgasmic capacity would represent a major leap forward. Such research could uncover novel molecular pathways involved in sexual function and identify individuals at higher genetic risk.

Second, the field urgently requires more sophisticated neuroimaging research. The current body of literature lacks direct functional imaging studies (e.g., fMRI) comparing the brain activity of women with and without FOD during sexual stimulation. Future studies should aim to map the neural circuits of orgasmic inhibition, exploring functional connectivity between key regions like the prefrontal cortex, limbic system (particularly the amygdala and temporal lobes), and brainstem centers (Özkara et al., 2006; Rotenberg, 2010). Such work could clarify whether FOD is characterized by hypoactivation in reward circuits, hyperactivation in inhibitory control regions, or altered connectivity between them.

Third, a more nuanced understanding of the neuropharmacology of orgasm is required. The paradoxical role of the 5-HT1A receptor, which may be involved in both generating orgasm and mediating the side effects of some antidepressants, warrants further investigation (Chen et al., 2017). Research into novel pharmacological agents that can selectively target pro-sexual receptor subtypes (e.g., 5-HT1A agonists, D2 agonists) while avoiding inhibitory ones could lead to the first approved medical therapy for FOD (Giraldi, 2024). This includes exploring the bidirectional relationship between orgasm and arousal, and whether treatments targeting one can benefit the other (Chen et al., 2017).

Fourth, the neurobiological heterogeneity of FOD needs to be explored. Lifelong versus acquired FOD, and generalized versus situational FOD, likely have different underlying pathophysiologies (Delcea, 2019). Future research should aim to identify distinct biological subtypes of the disorder. This could involve combining genetic, endocrine, and neuroimaging data to stratify patients, which may ultimately lead to more personalized treatment approaches. For example, are there specific hormonal profiles or patterns of neural activation that distinguish lifelong anorgasmia from an acquired, stress-related orgasmic difficulty?

Finally, the neuroplastic effects of psychological interventions should be investigated. While psychotherapies are known to be effective, their biological mechanisms are poorly understood (Fava et al., 2002). Longitudinal studies combining CBT or other therapies with neuroimaging could demonstrate how these interventions modify brain function and connectivity to restore orgasmic capacity. This would not only validate the biological impact of psychotherapy but could also help refine therapeutic techniques to more effectively target the specific neural dysfunctions underlying FOD.

### Conclusion

Female Orgasmic Disorder is a complex and highly prevalent condition that arises from a confluence of psychological, interpersonal, and biological factors (Snyder et al., 2016). This chapter has focused on synthesizing the evidence for the neurobiological substrates that contribute to its development and persistence. The evidence clearly indicates that FOD is not merely a "psychological" issue but is deeply rooted in the intricate functioning of the nervous and endocrine systems.

The central nervous system plays a paramount role, with a delicate balance of neurotransmitters—most notably serotonin and dopamine—being crucial for orgasmic function. The potent effects of psychotropic medications, particularly SSRIs and antipsychotics, provide a powerful pharmacological model for understanding how disruptions in these systems can lead to anorgasmia (Sonavane et al., 2023; Cubała, 2006). Key brain regions, including the emotion-processing limbic system, the regulatory frontal lobes, and the neuroendocrine command center of the hypothalamus, form a complex circuit whose proper integration is necessary for orgasm (Morrell, 1991; Miller et al., 1986).

The endocrine system, governed by the hypothalamic-pituitary-gonadal axis, provides the hormonal milieu essential for sexual response. Fluctuations in sex steroids like estrogen and testosterone, as well as the inhibitory influence of prolactin, directly impact both central mechanisms of desire and arousal and peripheral genital tissue health, all of which are prerequisites for orgasm (Balercia et al., 2007; Maguire, 2002).

Furthermore, the integrity of the peripheral and central neural pathways is critical, as demonstrated by the high rates of orgasmic dysfunction in neurological conditions such as multiple sclerosis, epilepsy, and spinal cord injuries (Kessler et al., 2009; Broglin, 2009). These conditions serve as natural experiments, illustrating how lesions in specific pathways can disconnect the genital sensory input from the brain's processing centers. Finally, a developmental neurobiology perspective underscores how early life experiences, such as trauma, can induce lasting changes in stress-response systems and brain architecture, creating a biological vulnerability to sexual dysfunction in adulthood (Verma & Agrawal, 2021).

In conclusion, the biological basis of Female Orgasmic Disorder is multifaceted, involving a distributed network of neurochemical, hormonal, and neural systems. While significant gaps in our knowledge remain, particularly in the areas of genetics and functional neuroimaging specific to FOD, the existing evidence provides a strong foundation. A comprehensive clinical approach must appreciate this biological complexity, recognizing that effective management may require interventions that target these underlying systems, whether through pharmacological adjustment, hormonal therapy, or psychotherapies that induce neuroplastic change. Continued research into these mechanisms is essential to move beyond associative findings and develop targeted, evidence-based treatments to alleviate the distress caused by this common disorder.

## References

1. Ab, S., Al, S., MIu, D., Aa, D., Ka, B., Sa, S., Av, B., & Vm, B. (2004). [Psychosomatic reactions comorbid with ischemic heart disease: psychogenically provoked infarctions and myocardial ischemia]..
2. Abay, H., & Kaplan, S. (2019). Current Approaches in Premenstrual Syndrome Management. Bezmialem Science. https://doi.org/10.14235/bas.galenos.2018.2358
3. Abbass, A., Grantmyre, J., & Kay, R. (2013). Anxiety related to sexual abuse: a case of recurrent priapism. Canadian Urological Association Journal. https://doi.org/10.5489/cuaj.233
4. Abdo, C. H. N. (2017). Sexualidade e doenças reumáticas. Revista Paulista de Reumatologia. https://doi.org/10.46833/reumatologiasp.2017.16.3.6-12
5. Abi‐Jaoude, E., Stall, N. M., & Rochon, P. A. (2018). Psychotropic drugs for the behavioural and psychological symptoms of dementia: no free ride. Canadian Medical Association Journal. https://doi.org/10.1503/cmaj.181486
6. Adam, S., & Osborne, S. (2009). Chapter 21 Metabolic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199215904.003.21
7. Adams, D., & Vohra, S. (2009). Complementary, Holistic, and Integrative Medicine: Nocturnal Enuresis. Pediatrics in Review. https://doi.org/10.1542/pir.30-10-396
8. Adi, Y., Ashcroft, D. M., Browne, K. D., Beech, A. R., Fry-Smith, A., & Hyde, C. (2002). Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders. Health Technology Assessment. https://doi.org/10.3310/hta6280
9. Adler, G. (2006). Diagnostik der Demenz. Notfall & Hausarztmedizin (Notfallmedizin). https://doi.org/10.1055/s-2006-959110
10. Agarwal, V., Sitholey, P., & Srivastava, C. (2019). Clinical practice guidelines for the management of dissociative disorders in children and adolescents. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_493_18
11. Agnew‐Blais, J., & Seidman, L. J. (2013). Attention deficit/hyperactivity disorder over the life course. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199657018.003.0014
12. Ahemad, M., Ahmad, P. M. F., & Shafaat, M. (2018). Effect of Dalak (Massage) in the Management of Sahar (Insomnia). https://doi.org/10.37591/rrjoush.v5i2.130
13. Akram, A. S., Sarwar, R., Zafar, M. F., Umair, M., Ullah, I., & Nazir, A. (2023). First oral treatment zuranolone’s FDA approval and its impact on postpartum depression: a new hope – a correspondence. International Journal of Surgery Global Health. https://doi.org/10.1097/gh9.0000000000000345
14. AL-Ibraheem, M. T. (2018). Cognitive Behavioral Therapy for Incest “Case Study”. Journal of Education and Practice.
15. Alanbagi, A. A., & Al-Zamily, R. H. (2019). The depression among cancer patients during chemotherapy and its relation to demographic and social data. International Journal of Research in Pharmaceutical Sciences.
16. Albano, A. M., & Silverman, W. K. (2024). Disruptive Mood Dysregulation Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348367.003.0016
17. Albano, A. M., & Silverman, W. K. (2024). Major Depressive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348367.003.0014
18. Albano, A. M., & Silverman, W. K. (2024). Major Depressive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348381.003.0014
19. Albano, A. M., & Silverman, W. K. (2024). Obsessive-Compulsive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348367.003.0012
20. Albano, A. M., & Silverman, W. K. (2024). Panic Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348381.003.0010
21. Albano, A. M., & Silverman, W. K. (2024). Tic Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348381.003.0019
22. Albrecht, S., Leineweber, C., Ojajärvi, A., Oksanen, T., Kecklund, G., & Härmä, M. (2020). Association of work-time control with sickness absence due to musculoskeletal and mental disorders: An occupational cohort study. Journal of Occupational Health. https://doi.org/10.1002/1348-9585.12181
23. Alexander, J. L., Sommer, B., Dennerstein, L., Grigorova, M., Neylan, T. C., Kotz, K., Richardson, G., & Rosenbaum, R. (2007). Role of psychiatric comorbidity on cognitive function during and after the menopausal transition. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.7.11s.s157
24. Alexandre, S., Misery, L., Dutray, S., Chastaing, M., Consoli, S.-M., Audra, H., Bauer, D., Bertolus, S., Callot, V., Cardinaud, F., Corrin, E., Féton-Danou, N., Malet, R., Touboul, S., & Consoli, S. (2007). Functional Itch Disorder or Psychogenic Pruritus: Suggested Diagnosis Criteria From the French Psychodermatology Group. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-0266
25. Alfarossi, O. L., & Hutasoit, H. B. K. (2020). Gejala Psikotik pada Pasien dengan Epilepsi Tidak Terkontrol. Jurnal Medula.
26. Ali, M. M., Saeed, M. A., Ebrahim, M., & Mandeel, F. (2023). Mortality Due to Complications Associated With Acute Ogilvie’s Syndrome in an Older Adult Treated for Psychosis: A Case Report. Cureus. https://doi.org/10.7759/cureus.51389
27. Alkan, A., Öztorun, H. S., Karcı, E., Ürün, Y., Tuncay, G., Yaşar, A., Çınar, E., Aras, S., Varlı, M., Utkan, G., Demirkazık, A., Akbulut, H., & Şenler, F. Ç. (2020). The Impact of Loneliness and Cancer Diagnosis on Cognitive Impairment in Geriatric Patients. Journal of Oncological Sciences. https://doi.org/10.37047/jos.2019-71889
28. Alloy, L. B., & Abramson, L. Y. (2010). Cyclothymic Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0249
29. Alvarado, R., Shilling, S., & Jorquera, M. J. (2015). Uso de la Intervención Critical Time Intervention en personas con primer episodio de psicosis. Revista de la Facultad de Ciencias Médicas de Córdoba. https://doi.org/10.31053/1853.0605.v72.n4.13845
30. Alvaro, M. (2019). Internal Structure and Consistency of the Spanish Version of the Six-Item Female Sexual Function Index. Perceptions in Reproductive Medicine. https://doi.org/10.31031/prm.2019.03.000556
31. Alves, D. C. L., Gross, J. D. S., Filho, J. D. L. D. C., Pinto, V. A. F. S., Roberto, G. F., Direito, V. C., Tiezzi, J. T. S., Pereira, E., & Gomes, N. P. (2025). DEPRESSÃO PÓS PARTO: UMA ANÁLISE SOBRE DIAGNÓSTICO E MANEJO ADEQUADO . Revista fisio&terapia.. https://doi.org/10.69849/revistaft/fa10202505101617
32. Amorim, M. J., Maurício, J., & Brandão, D. (2019). WHEN THE DISEASE ARISES FROM THE TREATMENT: CORTICOSTEROID-INDUCED PSYCHOSIS A CASE REPORT AND BRIEF LITERATURE REVIEW. https://doi.org/10.26226/morressier.5d1a037b57558b317a140b63
33. Anggela, S., & Hanum, N. A. (2020). HUBUNGAN KEBIASAAN BURUK ORAL (BAD ORAL HABITS) DENGAN KARIES PADA ANAK USIA PRA-SEKOLAH.
34. Angst, J., Rufer, M., Fineberg, N., Ajdacic‐Gross, V., & Rössler, W. (2015). Zwangsstörungen vom 20.–50. Altersjahr: Prävalenz, Komorbidität und Remission. Praxis. https://doi.org/10.1024/1661-8157/a002205
35. Antonioni, A., Peschi, G., & Granieri, E. (2020). A Case of Hyperekplexia That Started From Childhood: Clinical Diagnosis With Negative Genetic Investigations. Frontiers in Neurology. https://doi.org/10.3389/fneur.2020.00010
36. Antoniuk, S. A. (2013). [Non-epileptic disorders in infancy and adolescence].. PubMed.
37. Arandjelovic, D., Misic, P., Serafimovic, S., & Petrovic, M. (2010). P01-366 - Psychiatric Syndromes and Disorders in Older Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70574-5
38. Arató, M. (1995). [Psychoendocrinology of menopause].. PubMed.
39. Arbus, C., & Camus, V. (2011). Les symptômes dépressifs de la maladie d’Alzheimer : trouble affectif Depressive symptoms in Alzheimer’s disease: a neuropsychiatric affective disorder.
40. Arcos, B. (2004). Female sexual function and response.. PubMed.
41. Aretouli, E., Malik, M., Widmann, C., Parker, A. M., Oh, E. S., & Vannorsdall, T. D. (2025). Cognitive and mental health outcomes in long covid. BMJ. https://doi.org/10.1136/bmj-2024-081349
42. Arias, J. L., García, A. A., Alemany, R. N. I., Ortiz, J.-P., Andero, R., Giraldo, J., Coronas, R., Ortíz, J. A., & Palao, D. (2019). Hiperprolactinemia en psicosis tempranas: ¿secundaria a estrés o a una regulación alterada de la secreción de prolactina?. Psicosomática y Psiquiatría.
43. Arnold, S. E. (1999). Schizophrenia. Humana Press eBooks. https://doi.org/10.1007/978-1-4612-1602-5_27
44. Arnone, J. M., & Conti, R. P. (2016). Kleine-Levin Syndrome: An Overview and Relevance to Nursing Practice. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/02793695-20160219-07
45. Arroyo, H., Klipstein, K., Ernst, C. L., & Finkel, J. H. (2016). Somatic Symptom and Related Disorders, Including Illness Anxiety, Factitious, Malingering, and Conversion Disorders. https://doi.org/10.1002/9781118654231.ch20
46. Arteaga, T. L., Amo, C., González, C. S., & Sánchez, D. H. (2013). Nonconvulsive status epilepticus and psychotic symptoms: case report.. PubMed. https://doi.org/10.1708/1292.14295
47. Arteaga, T. L., Amo, C., González, C. S., & Sánchez, D. H. (2016). Nonconvulsive status epilepticus and psychotic symptoms: case report Stato epilettico non convulsivo e sintomi psicotici: caso clinico.
48. Athanasou, J. A. (2016). Substance Abuse. SensePublishers eBooks. https://doi.org/10.1007/978-94-6300-657-6_17
49. Atmaca, M. (2020). &lt;p&gt;Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives&lt;/p&gt;. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s185757
50. Autor, J. L. M. C., & Principal, C. M. A. C. O. T. (2018). Demencia tipo Alzheimer vs pseudo demencia por depresión. Estudio neuropsicológico de un caso. XII CONGRESO DE POSGRADO EN PSICOLOGÍA | UNAM | 2018.
51. Backlund, S., Nordström, J., & Bodlund, O. (2005). [Sexual problems are common during antidepressive treatment. What do general practitioners know about this adverse effect and how is it handled?].. PubMed.
52. Badalyan, О. L., Avakyan, G. N., & Chukanova, A. S. (2016). Reproductive disorders in male patients with epilepsy. DOAJ (DOAJ: Directory of Open Access Journals).
53. Bakheet, M. R., & Boyce, H. W. (2005). Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease.. PubMed.
54. Baldwin, D. S., & Mayers, A. (2003). Sexual side-effects of antidepressant and antipsychotic drugs. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.9.3.202
55. Baldwin, D. S., Ajel, K., & Garner, M. (2008). Anxiety disorders. Medicine. https://doi.org/10.1016/j.mpmed.2008.05.002
56. Balercia, G., Boscaro, M., Lombardo, F., Carosa, E., Lenzi, A., & Jannini, E. A. (2007). Sexual Symptoms in Endocrine Diseases: Psychosomatic Perspectives. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000099840
57. Barakat, B., Agosti, R., Ruggeri, E., Tonini, V., Cervellera, M., Guidetti, E., Cevenini, M., Imbrogno, A., Fabbri, D., Pareo, I., Fucili, A., Corinaldesi, R., Stanghellini, V., Pezzilli, R., & Giorgio, R. D. (2012). Atypical presentation of acute idiopathic megacolon in a 14-year-old patient. Emergency Care Journal. https://doi.org/10.4081/ecj.2012.3.5
58. Barbeau, G. (2006). La sexualité de la personne âgée et les médicaments. Santé mentale au Québec. https://doi.org/10.7202/030083ar
59. Barnes, T. R. E., & Paton, C. (2011). Do antidepressants improve negative symptoms in schizophrenia?. BMJ. https://doi.org/10.1136/bmj.d3371
60. Bass, C., & Wade, D. T. (2018). Malingering and factitious disorder. Practical Neurology. https://doi.org/10.1136/practneurol-2018-001950
61. Bassalo, J. M. F., Cattani, M., Filho, J. P., & Souza, N. S. M. D. (2009). Could Adrenaline Positive Help to Prevent Psychosomatic Illnesses ?. arXiv (Cornell University). https://doi.org/10.48550/arxiv.0903.1275
62. Basson, R., & Gilks, T. (2018). Women’s sexual dysfunction associated with psychiatric disorders and their treatment. Women s Health. https://doi.org/10.1177/1745506518762664
63. Bauman, K. A. (2009). Sexually transmitted diseases. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511642111.012
64. Baumann, P., & Martin-Du, P. R. (2008). Sexual dysfunctions induced by antidepressants and antipsychotics.
65. Beach, S. R. H., & Gupta, M. (2005). Marital Discord in the Context of a Depressive Episode: Research on Efficacy and Effectiveness. Family Psychology. https://doi.org/10.1093/oso/9780195135572.003.0019
66. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
67. Behere, P. B., Behere, A. P., Chowdhury, D., Nagdive, A., & Yadav, R. (2020). Effect of Marriage on Pre-existing Psychoses: A Convenient or Futile Solution for Severe Mental Disorders?. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820971738
68. Bello, Y. S. (2024). A Review on Sick Building Syndrome (SBS). Asian Journal of Science Technology Engineering and Art. https://doi.org/10.58578/ajstea.v3i1.4280
69. Benedict, C., & Nelson, C. J. (2016). Psychological assessment of patients with ED. https://doi.org/10.1002/9781118746509.ch14
70. Bereda, G. (2021). Classifying Causality of an Adverse Drug Reaction: Naranjo Algorithm. International Journal of Pharmacy and Chemistry. https://doi.org/10.11648/j.ijpc.20210706.14
71. Bereda, G. (2021). Delineation and Classifications of Adverse Drug Reaction: Brief Communication. International Journal of Pharmacy and Chemistry. https://doi.org/10.11648/j.ijpc.20210706.13
72. Berner, P. (1971). H ypersexualitat im Rahmen der Kliiver-Bucy-Symptomatik nach traumatischem apallischem Syndrom F. Gerstenbrand und C. H. Liicking.
73. Bezerra, E. D. L., & Zimmermann, M. (2015). DISTÚRBIOS COMPORTAMENTAIS EM CÃES: Ansiedade por Separação.
74. Biggs, Q. M., Guimond, J. M., Fullerton, C. S., Ursano, R. J., Gray, C. L., Goldenberg, M., Reissman, D. B., McCarroll, J. E., Santiago, P. N., & Tyler, M. P. (2012). The Epidemiology of Acute Stress Disorder and Other Early Responses to Trauma in Adults. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195399066.013.0006
75. Blanken, M. A. J. T., Overvliet, G. M., & Veen, G. (2023). [Patient with fetal alcohol spectrum disorder].. PubMed.
76. Blümel, J. E., & Arteaga, E. (2017). Los riesgos de no usar terapia hormonal de la menopausia: deterioro de la calidad de vida. Revista médica de Chile. https://doi.org/10.4067/s0034-98872017000600760
77. Boeft, M. D., Dessel, N. C.-V., & Wouden, J. C. V. D. (2017). How should we manage adults with persistent unexplained physical symptoms?. BMJ. https://doi.org/10.1136/bmj.j268
78. Bos, G. V. D., Nuijen, J., & Schellevis, F. (2010). Diagnose en behandeling van depressie bij lichamelijk zieke mensen in de huisartsenpraktijk.
79. Bostankolu, G., Ayhan, Y., Çetin, F. Ç., & Yazıcı, M. K. (2014). Serotonin syndrome with a combination of aripiprazole and fluoxetine: a case report. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125314561467
80. Boughton, B. J. (1991). Hepatic and portal vein-thrombosis.. BMJ. https://doi.org/10.1136/bmj.302.6770.192
81. Bouras, G., & Lazaratou, E. (2012). [Emergence of early childhood trauma in adult psychiatric symptomatology].. PubMed.
82. Bouvard, M., Milliery, M., & Cottraux, J. (2004). Management of Obsessive Compulsive Disorder. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000076452
83. Brannigan, R. E. (2010). Ejaculatory Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-536-1_19
84. Bravalhieri, A. A. V., Dontechef, P. D. S., Santos, J. D., Decanine, D., Pegorare, A. B. G. D. S., & Velasques, D. Z. (2016). Avaliação eletromiográfica dos músculos do assoalho pélvico em mulheres portadoras de Esclerose Múltipla e Mielopatia Associada ao HTLV-1 (HAM/TSP). 12º Congresso Internacional da Rede Unida.
85. Bravo, B., González, S. M. B., Portilla, N. O., Laynez, M. E. G., Gutiérrez, N. S., & Sánchez, F. G. (2024). Schizophreniform disorder. Clinical manifestations and diagnosis. Purposely a case. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1542
86. Brech, G. C., Andrusaitis, S. F., Vitale, G. F., & Greve, J. M. D. (2012). Correlation of disability and pain with postural balance among women with chronic low back pain. Clinics. https://doi.org/10.6061/clinics/2012(08)17
87. Brody, D. L. (2019). How Do You Make the Diagnosis of Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0003
88. Broglin, D. (2009). Troubles sexuels chez les patients épileptiques. Epilepsies. https://doi.org/10.1684/epi.2009.0277
89. Bronner, G., Elran, E., Golomb, J., & Korczyn, A. D. (2010). Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.2009.01314.x
90. Bronner, G., Royter, V., Korczyn, A. D., & Giladi, N. (2004). Sexual Dysfunction in Parkinson's Disease. Journal of Sex & Marital Therapy. https://doi.org/10.1080/00926230490258893
91. Brooks, C. N., Talmage, J. B., & Mueller, K. L. (2012). Subjective, Objective, or Both?. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2012.marapr02
92. Broomfield, N. M., Wild, M. R., & Espie, C. A. (2008). Assessment and treatment of insomnia in later life. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780198569459.003.0011
93. Brown, S. L. (2006). Deterioration. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00682.x
94. Brubaker, L. W., & Guntupalli, S. R. (2020). Female Sexual Dysfunction. Obstetrics and Gynecology. https://doi.org/10.1097/aog.0000000000003941
95. Bruno, V., & Fox, S. H. (2014). Tremor‐Predominant Fragile X‐Associated Tremor/Ataxia Syndrome in a Female. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.12129
96. Brüne, M. (2015). Forensic aspects of psychiatric disorders. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780198717942.003.0021
97. BSc, P. L. G. R., & BSc, D. B. R. (2008). Glossary of Technical Terms. https://doi.org/10.1002/9781444302264.gloss
98. Buckley, P., & Foster, A. (2014). Schizophrenia. https://doi.org/10.1007/978-3-7091-0715-7_4
99. Budiman, M. W. (2002). MODULASI RESPONS IMUN PADA MENCIT BALB/c YANG STRES AKIBAT STRESOR SUARA.
100. Bujosa, H. B. C., Rodríguez-Montalbán, R., & Rosario-Rodríguez, A. (2017). Análisis de las Propiedades Psicométricas de la Escala Crespo-Bujosa de Síntomas Neurológicos Discretos.. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.7714/cnps/11.1.2012
101. Burdett, H., Greenberg, N., Fear, N. T., & Jones, N. (2014). The mental health of military veterans in the UK. International Psychiatry. https://doi.org/10.1192/s1749367600004665
102. Buster, J. E. (2018). Sexual Dysfunction: Hypoactive Sexual Desire Disorder. https://doi.org/10.2310/obg.19105
103. Busto, E. D., Stoddard, F. R., & Cruz, J. S. (2016). Sexual Behaviors in Sleep. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780190245863.003.0003
104. Bäckström, T., & Hammarbäck, S. (1991). Premenstrual Syndrome—Psychiatric or Gynaecological Disorder?. Annals of Medicine. https://doi.org/10.3109/07853899109148094
105. Cadoret, R. J., & Winokur, G. (1972). Genetic Principles in the Classification of Affective Illnesses. International Journal of Mental Health. https://doi.org/10.1080/00207411.1972.11448572
106. Calderón, G. (2021). Adicción al sexo. Revista Española de Drogodependencias.
107. Calva, E. A., & González, C. M. (2020). Presencia, severidad y frecuencia de síntomas en mujeres climatéricas pacientes del Instituto Nacional de Perinatología. Psicología y Salud. https://doi.org/10.25009/pys.v30i2.2655
108. Camacho, M., Moura, A. R., & Oliveira‐Maia, A. J. (2018). Compulsive Sexual Behaviors Treated With Naltrexone Monotherapy. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.17l02109
109. Campbell, M., & Stein, D. J. (2014). Hypersexual disorder in general practice. South African Medical Journal. https://doi.org/10.7196/samj.8409
110. Capaldi, D. M., & Kim, H. K. (2014). Comorbidity of Depression and Conduct Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199797004.013.015
111. Caraiane, A., Szalontay, A. S., Macovei, L. A., Romila, A., Indrei, L. L., Decusară, M., & Tarc, T. (2018). Oral-Facial Manifestations Caused by the Use of Psychotropic Medication in Psychiatric Patients. Revista de Chimie. https://doi.org/10.37358/rc.18.6.6374
112. Carlini, S. V., & Deligiannidis, K. M. (2020). Evidence-Based Treatment of Premenstrual Dysphoric Disorder. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.19ac13071
113. Carlson, G. A., & Pataki, C. (2016). Disruptive Mood Dysregulation Disorder Among Children and Adolescents. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/appi.focus.20150039
114. Carpita, B., Nardi, B., Pronestì, C., Parri, F., Giovannoni, F., Cremone, I. M., Pini, S., & Dell’Osso, L. (2023). May Female Autism Spectrum Be Masked by Eating Disorders, Borderline Personality Disorder, or Complex PTSD Symptoms? A Case Series. Brain Sciences. https://doi.org/10.3390/brainsci14010037
115. Carrasco, M. M. (2008). Actualización en el manejo de las demencias en atención primaria. Jano: Medicina y humanidades.
116. Carvajal-Lohr, A., Flores‐Ramos, M., Montejo, S. I., & Vidal, C. G. (2016). Los trastornos de ansiedad durante la transición a la menopausia. Perinatología y Reproducción Humana. https://doi.org/10.1016/j.rprh.2016.03.003
117. CARVALHO, C. A., & SERRANO, L. F. (2007). TRATAMENTO DO RONCO E APNÉIAS DO SONO COM APARELHO INTRA-BUCAL. DENS. https://doi.org/10.5380/rd.v15i2.9440
118. Carvalho, M. M. D., & Góis, C. (2011). HIPERPROLACTINÉMIA EM DOENTES PSIQUIÁTRICOS.
119. Casanova, Y. C., Torres, M. N., Ramírez, M. D. L., Ferrer, A. B., Calvo, R. N., & Ramos, I. J. (2021). Plan de cuidados de enfermería para paciente con deterioro de la movilidad.. Revista Sanitaria de Investigación.
120. Cernovsky, Z. Z., Ferrari, J. R., & Mendonça, J. D. (2019). Deceptive Clinical Diagnosing of Malingering via Structured Inventory of Malingered Symptomatology. Archives of Psychiatry and Behavioral Sciences. https://doi.org/10.22259/2638-5201.0201009
121. Challacombe, F., & Wroe, A. L. (2013). A hidden problem: consequences of the misdiagnosis of perinatal obsessive–compulsive disorder. British Journal of General Practice. https://doi.org/10.3399/bjgp13x667376
122. Chandler, J. A., Mogyoros, A., Rubio, T. M., & Racine, É. (2013). Another Look at the Legal and Ethical Consequences of Pharmacological Memory Dampening: The Case of Sexual Assault. The Journal of Law Medicine & Ethics. https://doi.org/10.1111/jlme.12096
123. Chaouloff, F., Dubreucq, S., Matias, I., & Marsicano, G. (2013). Physical activity feel-good effect:The role of endocannabinoids. Routledge eBooks. https://doi.org/10.4324/9780203132678-12
124. Charbonnier, V., Roy, A., Seegmüller, C., Gautier, A., & Gall, D. L. (2011). Étude d'un cas de syndrome dysexécutif à prédominance cognitive chez un enfant présentant une épilepsie frontale symptomatique. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2011.0161
125. Charmaz, K. (2007). Chronic Illness and Disability. The Blackwell Encyclopedia of Sociology. https://doi.org/10.1002/9781405165518.wbeosc035
126. Chatterton, C., & Jones, G. (2013). Interpretative aspects of toxicological results. https://doi.org/10.4155/ebo.13.54
127. Chaturvedi, S. K. (1987). Depressive psychosis presenting as chronic pain disorder.. PubMed.
128. Chaudhry, S. (2020). Depression and its Dilemma. IP Journal of Surgery and Allied Sciences. https://doi.org/10.18231/j.jsas.2020.013
129. Chavan, R., Gosavi, M., Baviskar, M., & Goyal, N. P. (2023). Depression Detection using AI, ML and NLP. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-8886
130. Chaves, F. D. S., Vargas, M. M., & Farias, D. L. D. (2018). ANÁLISE DE FORÇA MUSCULAR, EQUILÍBRIO E CAPACIDADE FUNCIONAL EM PACIENTES COM ESCLEROSE MÚLTIPLA: INTERVENÇÃO MULTIDISCPLINAR. Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa. https://doi.org/10.5102/pic.n1.2015.5471
131. Chen, W.-H., Chu, Y.-H., & Chen, K.-Y. (2017). Drug-Associated Spontaneous Orgasm: A Case Report and Systematic Review of Literature. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000259
132. Chen, Y.-S. (2012). Association between chronic insomnia and depression in elderly adults. Journal of the Chinese Medical Association. https://doi.org/10.1016/j.jcma.2012.04.001
133. Chojnowski, J., Więdłocha, M., & Mosiołek, A. (2017). Zaburzenia seksualne u pacjentów ze schizofrenią.
134. Church, H. A., & Lucey, J. V. (2010). Anxiety disorders in women. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199214365.003.0010
135. Ciraulo, D. M., & Ciraulo, D. A. (2008). Benzodiazepines <i>Misuse, Abuse, and Dependence</i>. https://doi.org/10.1093/oso/9780195300550.003.0019
136. Clayton, A. H. (2002). Female sexual dysfunction related to depression and antidepressant medications.. PubMed.
137. Clayton, A., Dennerstein, L., Pyke, R. E., & Sand, M. (2010). Flibanserin: A Potential Treatment for Hypoactive Sexual Desire Disorder in Premenopausal Women. Women s Health. https://doi.org/10.2217/whe.10.54
138. Coccolini, F., Improta, M., Picetti, E., Vergano, L. B., Catena, F., Angelis, N. D., Bertolucci, A., Kirkpatrick, A. W., Sartelli, M., Fugazzola, P., Tartaglia, D., & Chiarugi, M. (2020). Timing of surgical intervention for compartment syndrome in different body region: systematic review of the literature. World Journal of Emergency Surgery. https://doi.org/10.1186/s13017-020-00339-8
139. Cohen, R., Pereira, I., Garrido, M. M., Ferreira, B., & Sousa, M. D. C. (2023). Suicidal ideation in older people, a public health matter. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.1786
140. Colpi, E. M., Piediferro, G., Castiglioni, F., & Nerva, F. (2004). Premature ejaculation. 1. Definition and etiology.. PubMed.
141. Conaglen, H. M., & Conaglen, J. V. (2013). Drug-induced sexual dysfunction in men and women. Australian Prescriber. https://doi.org/10.18773/austprescr.2013.021
142. Contreras, V., & Sobeida, M. (2019). Factores estresantes y fobia social en una adolescente.
143. Conway, K. P., Montoya, I. D., & Compton, W. M. (2007). Lifetime Psychiatric Comorbidity of Illicit Drug Use Disorders. The Psychiatric times.
144. Coppen, A., & Swade, C. (1988). 5-HT and Depression: the Present Position. https://doi.org/10.1007/978-1-349-09506-3_9
145. Corniola, M. V., Tessitore, E., Schaller, K., & Gautschi, O. (2015). [Cervical disc herniation--diagnosis and treatment].. PubMed.
146. Corona, G., Forti, G., & Maggi, M. (2006). Il desiderio sessuale ipoattivo nell'uomo: il ruolo dell'andrologo.
147. Corona, G., Mannucci, E., Petrone, L., Fisher, A. D., Balercia, G., Scisciolo, G. D., Pizzocaro, A., Giommi, R., Chiarini, V., Forti, G., & Maggi, M. (2006). Psychobiological Correlates of Delayed Ejaculation in Male Patients With Sexual Dysfunctions. Andrology. https://doi.org/10.2164/jandrol.05154
148. Couto, F. S. D., & Mendonça, A. D. (2010). Sintomas psiquiátricos e comportamentais da demência. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v26i1.10713
149. Cox, R. C., Wright, K. P., Axelsson, J., & Balter, L. J. T. (2024). Diurnal variation in anxiety and activity is influenced by chronotype and probable anxiety-related disorder status. Psychiatry Research. https://doi.org/10.1016/j.psychres.2024.116006
150. Crisp, A. H., & Toms, D. A. (1972). Primary Anorexia Nervosa or Weight Phobia in the Male: Report on 13 Cases. BMJ. https://doi.org/10.1136/bmj.1.5796.334
151. Cristofor, A.-C., Popa, T., Crețeanu, A., Rusu, G., & Mititelu-Tarțău, L. (2016). Farmacoterapia depresiei la pacientul vârstnic. Farmacist ro.
152. Cruz, M. P. (2011). Lurasidone HCl (Latuda), an Oral, Once-Daily Atypical Antipsychotic Agent for the Treatment of Patients with Schizophrenia.. PubMed.
153. Cui, Y., Li, L., Chen, S., Zhao, Q., Li, L., & Gu, Z. (2017). AB0513 Fatigue in chinese patients with primary sjÖgren's syndrome: a cross sectional study. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2017-eular.3076
154. Cui, Y., Li, L., Zhao, Q., Chen, S., Li, L., & Gu, Z. (2017). AB0543 Anxiety and depression in chinese patients with primary sjÖgren's syndrome. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2017-eular.3069
155. Cuijpers, P. (2010). Postpartum Depression. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0697
156. Cumberbatch, C.-J., Birndorf, C., & Dresner, N. (2006). Psychological implications of high-risk pregnancy.. International journal of fertility and women's medicine/International journal of fertility & women's medicine.
157. Cunningham, J., Yonkers, K. A., O’Brien, S., & Eriksson, E. (2009). Update on Research and Treatment of Premenstrual Dysphoric Disorder. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220902891836
158. Czajkowska‐Malinowska, M., & Cofta, S. (2014). Obturacyjny bezdech senny i jego społeczne następstwa.
159. D'Agati, S., Teodoro, M. C., Tomaselli, T., Barbera, N., D’Agati, A., & Zarbo, G. (2011). Depressione post-partum: valutazione clinica e medico-legale.
160. Daley, D. C., & Douaihy, A. (2019). Substance-Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0002
161. Davis, K. (2009). Evaluation of University of Buffalo's ADHD Summer Treatment Program developed by Dr. William Pelham, Jr., based on evidence-based treatments of ADHD.
162. Davis, N. J. (2017). Prefrontal electrical stimulation in non-depressed reduces levels of reported negative affects from daily stressors. Frontiers in Human Neuroscience. https://doi.org/10.3389/fnhum.2017.00063
163. Debiais, S., Bonnaud, I., Ferreira-Maldent, N., Mercier, E., & Toffol, B. D. (2009). NEUROPSYCHIATRIC DISORDERS REVEALING PRIMARY ANTIPHOSPHOLIPID SYNDROME IN AN ELDERLY PATIENT. Neurology. https://doi.org/10.1212/wnl.0b013e3181a0fd69
164. Deep, A. L., Nagy, L., Weltzin, T. E., Rao, R., & Kaye, W. H. (1995). Premorbid onset of psychopathology in long‐term recovered anorexia nervosa. International Journal of Eating Disorders. https://doi.org/10.1002/1098-108x(199504)17:3<291::aid-eat2260170310>3.0.co;2-#
165. Dehanov, S., & Ferreira, T. (2019). AN IMMACULATE CONCEPTION – THE DIFFERENTIAL DIAGNOSIS OF A DELUSION OF PREGNANCY. https://doi.org/10.26226/morressier.5d1a037857558b317a14085a
166. Delanerolle, G., Shetty, S., Raymont, V., Hapangama, D. K., Haque, N., Shi, J. Q., Ayis, S., Shetty, A., & Phiri, P. (2021). None. LOJ Medical Sciences. https://doi.org/10.32474/lojms.5.5
167. Delcea, C. (2019). Dyspareunia in men. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.11.120
168. Delcea, C. (2019). Orgasmic disorder in men. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.115
169. Delcea, C. (2019). Orgasmic disorder in women. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.11.122
170. Delcea, C. (2019). Sexual deviances. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.119
171. Delgado, D. A. O., Rojas, M. C. O., & Olea, J. M. S. (2024). Episodio depresivo mayor de características catatónicas: Reporte de caso. Revista Científica de Salud y Desarrollo Humano. https://doi.org/10.61368/r.s.d.h.v5i1.75
172. DeLuca, G. C., & Bartleson, J. D. (2010). When and How to Investigate the Patient with Headache. Seminars in Neurology. https://doi.org/10.1055/s-0030-1249221
173. Denysenko, M. (2018). ДІАГНОСТИЧНІ КРИТЕРІЇ НЕВРАСТЕНІЇ З ПІДВИЩЕНИМ РИЗИКОМ АДИКТИВНОЇ ПОВЕДІНКИ. Вісник соціальної гігієни та організації охорони здоров я України. https://doi.org/10.11603/1681-2786.2017.3.8270
174. Derman, E., Whitesman, S., Dreyer, M., Patel, D., Nossel, C., & Schwellnus, M. (2010). Healthy lifestyle interventions in general practice: Part 12: Lifestyle and depression. South African Family Practice. https://doi.org/10.1080/20786204.2010.10873989
175. Dewailly, D., & Néraud, B. (2007). Drug-Induced Hyperandrogenism. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-179-6_10
176. Dharani, A. (2020). Sleep Paralysis and the Structure of Waking. Journal of Sleep Disorders Treatment & Care. https://doi.org/10.37532/jsdtc.2020.9(4).238
177. Diarra, E., Jedynak, C. P., & Verny, M. (2008). [Tremor in the elderly].. PubMed. https://doi.org/10.1684/pnv.2008.0139
178. Dias, R. D. S. (2010). Estudo comparativo do fenótipo clínico de mulheres com transtorno afetivo bipolar em fase reprodutiva da vida com e sem piora pré-menstrual do humor. https://doi.org/10.11606/t.5.2010.tde-28052010-101220
179. Dijkstra, B. (2009). Een evenwichtstoornis??? : de belangrijkste aandachtspunten in de psychomotorische therapie bij de behandeling van volwassenen met psychosomatische klachten in combinatie met een licht tot matige verstandelijke beperking.
180. Dilsaver, S. C., Halle, M. H., & Medico, V. J. D. (1991). Symptoms of major depression: acute effect of withdrawing antidepressants. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1991.tb05531.x
181. Djahnit, H., Mehdi, S., & Labidi, A. (2024). social and psychological problems experienced by people with chronic diseases in Algeria. International Journal of Health Sciences. https://doi.org/10.53730/ijhs.v8ns1.14694
182. Dodd, M. L. (2007). BASIC PRINCIPLES OF PSYCHIATRY. CRC Press eBooks. https://doi.org/10.1201/b14430-11
183. Dreschnack, P. A., Scott, M., & Bochenek, C. (2020). Case Report: Bell’s Palsy and Stem Cell Therapy. Journal of Regenerative Medicine.
184. Dreyer-Oren, S. E., Mitnaul, L., & Holtzheimer, P. E. (2018). Mood Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy25
185. Drossman, D. A. (1997). Irritable bowel syndrome and sexual/physical abuse history. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/00042737-199704000-00002
186. Drouet, A. (2013). [Management of muscle cramp: what's to be done?].. PubMed.
187. Dugué, S. (2020). Les spécificités du syndrome douloureux régional complexe de type 1 (SDRC 1) en pédiatrie. Douleur et Analgésie. https://doi.org/10.3166/dea-2020-0141
188. Dulz, B., & Schreyer, D. (1997). [The problems in dealing with the incest experiences of borderline patients].. PubMed.
189. Dunphy, L., Boyle, S., & Wood, F. (2023). The multifactorial aetiology and management of premenstrual dysphoric disorder with leuprorelin acetate. BMJ Case Reports. https://doi.org/10.1136/bcr-2023-258343
190. Duval, F., Jautz-Duval, M. M., González, F., & Rabia, H. (2010). Bases neurobiológicas de vulnerabilidad psiquiátrica a lo largo de las etapas de la vida hormonal de la mujer. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272010000500005
191. Díaz, C. M., Solá, M. G., & Sánchez, M. T. (2013). Enfermedad de Creutzfeldt-Jacob: [caso clínico].
192. Dılbaz, N., & Enez, A. (2013). Treatment of Generalized Anxiety Disorders: Unmet Needs. InTech eBooks. https://doi.org/10.5772/53453
193. D’cruz, M., Andrade, C., & Rao, T. S. (2020). The Expression of Intimacy and Sexuality in Persons With Dementia. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820972859
194. Eb, B. (1991). [Clinical characteristics of vital depersonalization in schizophrenia].. PubMed.
195. Eberlein-König, B., Rakoski, J., Ruhdorfer, S., Huss‐Marp, J., Grimm, V., Behrendt, H., & Ring, J. (2003). Idiopathic Environmental Intolerances: Psychosomatic and Somatic Aspects. Dermatology and Psychosomatics / Dermatologie und Psychosomatik. https://doi.org/10.1159/000070534
196. Egan, J., & Kenny, M. (2011). Somatization Disorder: What Clinicians Need to Know.
197. Eiden, C., Cathala, P., Fabresse, N., Galea, Y., Mathieu-Daudé, J.-C., Baccino, É., & Peyrière, H. (2013). A Case of Drug-Facilitated Sexual Assault Involving 3,4-methylene-dioxy-methylamphetamine. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2013.763573
198. El-Hamady, M. M., El-Sayed, H., Bakry, S. E., & Youniss, M. (2020). Prevalence of Anxiety Disorders in Substance Related Disorders. Benha Journal of Applied Sciences. https://doi.org/10.21608/bjas.2020.137193
199. El-Sorogy, S. E., El-Hamady, M. M., Mohamed, A. S., & Dahroug, M. M. M. (2024). Sexual Disorders in Females with Bipolar Disorder. Benha Journal of Applied Sciences. https://doi.org/10.21608/bjas.2024.275914.1354
200. Enrique, P. M. L., Gloria, A. S., Efraín, S. C. J., & Luis, G. A. J. (2019). Latencia diagnóstica en la enfermedad de Parkinson y su relación con los síntomas prodrómicos motores y no motores. eNeurobiología.
201. Epelbaum, S., & Dubois, B. (2013). [Subjective cognitive complaint. From anxiety to prodromal Alzheimer's disease?].. PubMed.
202. Eriksen, H. R., & Ihlebæk, C. (2002). Subjective health complaints. Scandinavian Journal of Psychology. https://doi.org/10.1111/1467-9450.00274
203. Ettore, B., & Beghi, M. (2013). Gender Difference in Epidemiology and Comorbidities of Epilepsy. https://doi.org/10.1002/9781118531037.ch1
204. Fabre, L. F., Clayton, A. H., Smith, L. C., Goldstein, I. M., & Derogatis, L. R. (2013). Association of Major Depression With Sexual Dysfunction in Men. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.12010004
205. Fachrudin, D. (2018). Skizofrenia Simpleks (sebuah studi kasus perspektif psikologi). Tunas Medika Jurnal Kedokteran & Kesehatan.
206. Fachrudin, D. (2019). Episode Depresif Berat dengan Gejala Psikotik (Studi Kasus dalam Perspektif Psikologi dengan Pendekatan Teori Kognitif Beck). Tunas Medika Jurnal Kedokteran & Kesehatan.
207. Factor, S. A., Molho, E., Podskalny, G. D., & Brown, D. (1995). Parkinson's disease: drug-induced psychiatric states.. PubMed.
208. Factor, S. A., Podskalny, G. D., & Molho, E. (1995). Psychogenic movement disorders: frequency, clinical profile, and characteristics.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.59.4.406
209. Falk, A., Joseph, R., Smith, S., & Wilk, A. (2023). Mood and Anxiety Disorders: Major Depressive Disorder.. PubMed.
210. Farah, A. (1999). Relief of SSRI-Induced Sexual Dysfunction With Mirtazapine Treatment. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v60n0412a
211. Farkas, J., Rigó, A., & Demetrovics, Z. (2013). Psychological aspects of the polycystic ovary syndrome. Gynecological Endocrinology. https://doi.org/10.3109/09513590.2013.852530
212. Fava, G. A., Ruini, C., & Sonino, N. (2002). Management of Recurrent Depression in Primary Care. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000067189
213. Fekih‐Romdhane, F., Abassi, B., Baccar, F., Cheour, M., Sana, E., & Damak, R. (2024). The Impact of Psychotropics on Sexuality: A Literature Review. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1600
214. Feldman, J., & Larsen, K. (2014). Sexual Dysfunction. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199797004.013.032
215. Feliciano, R., & Alfonso, C. A. (1997). Sexual Side Effects of Psychotropic Medication—Diagnosis, Neurobiology, and Treatment Strategies. International Journal of Mental Health. https://doi.org/10.1080/00207411.1997.11449389
216. Fernández‐Alcántara, M., Pérez‐Marfil, M. N., Catena, A., Pérez‐García, M., & Cruz‐Quintana, F. (2015). Influencia de la psicopatología emocional y el tipo de pérdida en la intensidad de los síntomas de duelo. Revista Iberoamericana de Psicología y Salud. https://doi.org/10.1016/j.rips.2015.10.002
217. Fiebai, P. O., Ukueku, A. O., & Ogu, R. (2019). Pre Menstrual Syndrome. IntechOpen eBooks. https://doi.org/10.5772/intechopen.80492
218. Findling, J. W., & Raff, H. (2017). DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing’s syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing’s syndrome). European Journal of Endocrinology. https://doi.org/10.1530/eje-16-0946
219. Fisher, A. D., Bandini, E., Casale, H., & Maggi, M. (2011). Paraphilic Disorders: Diagnosis and Treatment. https://doi.org/10.1002/9781119963820.ch8
220. Flores, C. (2010). FACTORES QUE INFLUYEN EN LA ADICCIÓN ADOLESCENTE. Contribuciones a las Ciencias Sociales.
221. Foa, E. B., Stein, D. J., & McFarlane, A. C. (2006). Symptomatology and psychopathology of mental health problems after disaster.. PubMed.
222. Forero, M. H., Tautiva, H., & Galindo, L. (2014). Subdiagnóstico de la fibromialgia en hombres: revisión de la literatura y reporte de un caso. Revista Colombiana de Medicina Física y Rehabilitación. https://doi.org/10.28957/rcmfr.v24n2a9
223. Fraga, A., Soares, F. R., Mesquita, B., Albuquerque, M., Facucho, J. O., Santos, P. E., Sousa, D., Moura, N., & Cintra, P. (2023). How sexuality is affected and managed in patients under antipsychotic drugs. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.2243
224. Frances, A. (2013). Essentials of psychiatric diagnosis : responding to the challenge of DSM-5. Guilford Press eBooks.
225. Franjić, S. (2023). Child Abuse and Neglect is a Serious Problem in Every Society. Deleted Journal. https://doi.org/10.33140/jre.01.01.03
226. Franz, M. R., & Schepank, H. (1997). [Mood disorders. Prevalence and course of unspecified functional disorders from the epidemiologic and psychosomatic viewpoint].. PubMed.
227. Freeman, M. P. (2011). The Menstrual Cycle and Mood: Premenstrual Dysphoric Disorder. Journal watch. https://doi.org/10.1056/wh201112210000001
228. Frey, W. H., & Thomas, A. (1995). Validation of the NINCDS-ADRDA Criteria Regarding Gait in the Clinical Diagnosis of Alzheimer Disease. Alzheimer Disease & Associated Disorders. https://doi.org/10.1097/00002093-199509030-00006
229. Frías, Á., Palma, C., Fernández, I. A., & Cirera, B. M. (2013). Propósito de un Caso: Masoquismo sexual: controversias etiopatogénicas y nosológicas a propósito de un caso. Cuadernos de medicina psicosomática y psiquiatria de enlace.
230. Führmann, F., Rößner-Ruff, V., Friedrich, K. J., Krieger, J. E., Hauser, C., Altunöz, U., Ziegenbein, M., & Graef-Calliess, I. (2021). „Geschlechterspezifische“ Unterschiede bei depressiven Erkrankungen? Untersuchung von „nicht-typischen“ Symptomen und Einflussfaktoren - Ergebnisse der „Male Depression“-Studie. Das Gesundheitswesen. https://doi.org/10.1055/s-0041-1732749
231. Ga, H. (1990). [Hormone substitution in the female climacteric--goals, means, effects].. PubMed.
232. Gaisbauer, G. (1999). Medikamentenbedingte Fahruntuechtigkeit und Fahrlaessigkeit. Zeitschrift fuer Verkehrsrecht.
233. Galasko, D. (2019). Pharmacological Approaches To Behavioral Symptoms In Alzheimer’s Disease. CRC Press eBooks. https://doi.org/10.1201/9780429260353-28
234. Gameleira, G. H., & Barbosa, M. L. S. (2019). MANIFESTAÇÕES ATÍPICAS DAS CRISES EPILÉPTICAS. Semana de Pesquisa do Centro Universitário Tiradentes - SEMPESq - Alagoas.
235. Ganasan, S. (2019). Managing depression in the primary care setting. Journal of Prescribing Practice. https://doi.org/10.12968/jprp.2019.1.8.388
236. Garay, M. A., Richards, S., Mj, M. U., & Luguercho, C. (2007). [Psychotic major depressive episode: target symptoms in males and females].. PubMed.
237. Garcia, F. D., & Thibaut, F. (2010). Sexual Addictions. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.3109/00952990.2010.503823
238. García‐Portilla, M. P. (2009). [Depression and perimenopause: a review].. PubMed.
239. Geier, D. A., & Geier, M. R. (2015). Understanding the Importance of the Evaluation and Treatment of Elevated Androgens in Autism Spectrum Disorder. InTech eBooks. https://doi.org/10.5772/59394
240. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
241. Ghogare, A. S., Patil, P. S., & Vankar, G. K. (2021). A Systematic Review of Childhood Psychological Traumas and Alexithymia Among Persons with Alcohol Dependence Syndrome. Annals of Indian Psychiatry. https://doi.org/10.4103/aip.aip_54_21
242. Giacomo, E. D., Alamia, A., Cicolari, F., Cimolai, V., & Clerici, M. (2014). [Sexual abuse in adulthood: when psychic and somatic suffering merge].. PubMed. https://doi.org/10.1708/1600.17454
243. Giacomo, E. D., Moretti, F., Colmegna, F., & Clerici, M. (2023). Obsessive–compulsive disorder as the onset of bipolar disorder in adolescence. Bipolar Disorders. https://doi.org/10.1111/bdi.13373
244. Giannandrea, S. A., Chaudron, L. H., & Grady-Weliky, T. A. (2024). Premenstrual Syndrome. CRC Press eBooks. https://doi.org/10.1201/9781003579038-11
245. Giannopoulos, I., Jupe, T., & Roumpou, A. (2024). Sexual dysfunction, depression, and the impact of antidepressants. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1120
246. Gillberg, C. (2010). Double Syndromes:Autism Associated with Genetic, Medical and Metabolic Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195342680.003.0008
247. Gillen, M., Rose, E., & Schwarze, J. (2014). Conduct Disorder. https://doi.org/10.63134/nbfb7032
248. Giraldi, A. (2024). Orgasmic Disorders. Clinical Obstetrics & Gynecology. https://doi.org/10.1097/grf.0000000000000917
249. Globas, C., Montcel, S. T. D., Baliko, L., Boesch, S., Depondt, C., DiDonato, S., Dürr, A., Filla, A., Klockgether, T., Mariotti, C., Melegh, B., Rakowicz, M., Ribaı̈, P., Rola, R., Schmitz‐Hübsch, T., Szymanski, S., Timmann, D., Warrenburg, B. P. V. D., Bauer, P., & Schöls, L. (2008). Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6. Movement Disorders. https://doi.org/10.1002/mds.22288
250. Goldfinger, C., & Pukall, C. F. (2011). Sexual Pain Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-916-1_12
251. Golding, J. M. (1999). Sexual-Assault History and Long-Term Physical Health Problems. Current Directions in Psychological Science. https://doi.org/10.1111/1467-8721.00045
252. Goldmeier, D., & Andrews, S. (2016). Persistent Genital Arousal Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780190245863.003.0008
253. Golightly, L., & Young, A. H. (1999). Sex hormones and mental health. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.5.2.126
254. Golubtsova, L. I., & Vasil'chenko, G. S. (1988). [Sexual disorders in women with slowly progressing schizophrenia].. PubMed.
255. González, M. I. L., Alfonso, C. A., Mederos, P. O., & León, A. G. A. D. (2006). Síndrome Neuroléptico Maligno en el manejo anestésico.. Revista Médica Electrónica.
256. González-Navarro, A., Martos-Pérez, J., Freire-Prudencio, S., Llorente-Comí, M., & Ayuda-Pascual, R. (2013). [Development and follow-up of autism spectrum disorders].. PubMed.
257. Graven‐Nielsen, T., & Arendt‐Nielsen, L. (2007). [Gender differences in response to pain].. PubMed.
258. Grejdean, T., Tintiuc, D., Victoria, G.-V., Goma, L., Globa, N., & Puia, R. (2025). Determining parameters of the cognitive disorders of the elderly population. Bulletin of the Academy of Sciences of Moldova Medical Sciences. https://doi.org/10.52692/1857-0011.2024.3-80.17
259. Grosso, S., Cioni, M., Pucci, L., Morgese, G., & Balestri, P. (1999). Selective mutism, speech delay, dysmorphisms, and deletion of the short arm of chromosome 18: a distinct entity?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.67.6.830
260. Gruber, G., Saletu‐Zyhlarz, G., Anderer, P., Metka, M., Huber, J. C., Grätzhofer, E., & Saletu, B. (2007). Insomnia During Menopause. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-115-4_18
261. Gudelius, C., & Mielke, R. (2008). Fahrtuechtigkeit bei der Alzheimer-Erkrankung. SCHRIFTENREIHE FAHREIGNUNG.
262. Guo, L., & He, Z. (2024). Case report: Depression in an older patient with dysgeusia as the initial symptom. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2024.1478359
263. Gupta, K., Parimal, B. S., & Patel, A. K. (2023). Mindfulness-Based Cognitive Therapy for Coping with Premenstrual Syndrome Distress. Advances in medical diagnosis, treatment, and care (AMDTC) book series. https://doi.org/10.4018/978-1-6684-5088-8.ch010
264. Gupta, Y., Chahar, A., & Sharma, S. (2024). A Case of “Telogen Effluvium” Cured by Individualized Medicine. Homœopathic Links. https://doi.org/10.1055/s-0044-1785233
265. Gutiérrez-Achury, A. M., Vanegas-Vidal, M., Salazar-Díaz, L. I., & Arías, G. M. A. (2009). Factores farmacológicos y no farmacológicos que afectan la adherencia al tratamiento de los pacientes esquizofrénicos dados de alta en la Unidad de Salud Mental del Hospital Universitario de Neiva entre enero y junio del 2008. RFS Revista Facultad de Salud. https://doi.org/10.25054/rfs.v1i2.43
266. Gyorfi, M., & Abd‐Elsayed, A. (2024). Pudendal nerve blockade for persistent genital arousal disorder (<scp>PGAD</scp>): A clinical review and case report. Pain Practice. https://doi.org/10.1111/papr.13362
267. Gómez‐Revuelta, M., Olivares, O. P., Ruíz, M. J., Puente, B. F. A., Herrera, M., Ayala, L., Rodríguez, R. L., Morales, N. N., Jenaro, G. P. D. S., & Blanco, L. S. (2017). Antidepressants and sexual dysfunction: study with vortioxetina. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.741
268. Gómez‐Tortosa, E., Rigual, R., Prieto-Jurczynska, C., Mahíllo, I., Guerrero, R., Pérez‐Pérez, J., & Sainz, M. J. (2015). Behavioral Evolution of Progressive Semantic Aphasia in Comparison with Nonfluent Aphasia. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000439521
269. Günaydın, F. M., & Tunç, A. (2024). Prevalence of restless genital syndrome and its impact on quality of life in women with restless legs syndrome. Neurological Research. https://doi.org/10.1080/01616412.2024.2424574
270. Güney, E., & İşeri, E. (2013). Genetic and Environmental Factors in Autism. InTech eBooks. https://doi.org/10.5772/53295
271. Hajnšek, S., Radić, B., Gadže, Ž. P., Nanković, S., Šulentić, V., & Anić, B. (2009). Induction of systemic lupus erythematosus in the patient with epilepsy treated with carbamazepine – a case report.
272. Hall, S., & Ibrahim, S. (2023). 0998 Duloxetine as a Possible Effective Treatment of Klein-Levin Syndrome Case Report. SLEEP. https://doi.org/10.1093/sleep/zsad077.0998
273. Hallengren, B. (1998). [Hypothyroidism--clinical findings, diagnosis, therapy. Thyroid tests should be performed on broad indications].. PubMed.
274. Hamami, F., Prasuhn, J., Well, L.-C. V., Lohmann, K., Klein, C., Brüggemann, N., Bäumer, T., Münchau, A., & Weißbach, A. (2025). Functional movement disorders in dopa-responsive dystonia. Parkinsonism & Related Disorders. https://doi.org/10.1016/j.parkreldis.2025.107292
275. Hamdan, M., & Machin, A. (2009). Restless Legs Syndrome. Airlangga University Press eBooks.
276. Hammett, E., Fernandez-Carbonell, C., Crayne, C. B., Boneparth, A., Cron, R. Q., & Radhakrishna, S. M. (2020). Adolescent Sjogren’s syndrome presenting as psychosis: a case series. Pediatric Rheumatology. https://doi.org/10.1186/s12969-020-0412-8
277. Hansch, D. (2019). Angst und psychosomatische Erkrankungen: Eskalationsmechanismen und therapeutische Strategien aus der Sicht von Systemtheorie und Verhaltenstherapie. Therapeutische Umschau. https://doi.org/10.1024/0040-5930/a001091
278. Harrianto, R., & Anatomi, B. (1999). OCCUPATIONAL OVERUSE SYNDROME.
279. Harrison, J., McIlwain, M. E., Wheeler, A., & Russell (2011). Pharmacotherapy for treatment-resistant schizophrenia. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s12769
280. Hartman, T. O., Woutersen-Koch, H., & Horst, H. E. V. D. (2013). Medically unexplained symptoms: evidence, guidelines, and beyond. British Journal of General Practice. https://doi.org/10.3399/bjgp13x675241
281. Hauser, G. (1999). HÄUFIGKEITDER EINZELNEN KLIMAK- TERISCHEN SYMPTOME UND IHR UNTERSCHIEDLICHES ANSPRECHEN AUF DIE HORMONERSATZTHERAPIE KLIMAKTERISCHE SYMPTOME UND HORMONERSATZ- THERAPIE.
282. Hellhammer, D. H., & Wade, S. E. (1993). Endocrine Correlates of Stress Vulnerability. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000288675
283. Hernández, Y. D. C. S. (2016). Alteraciones estructurales de las regiones cerebrales sexuales tras empleo de paroxetina versus agomelatina. https://doi.org/10.14201/gredos.129703
284. Herzog, A. G. (1982). Endocrine Dysfunction in Temporal Lobe Epilepsy-Reply. Archives of Neurology. https://doi.org/10.1001/archneur.1982.00510240049019
285. Hiestand, D. M., & Phillips, B. (2007). Restless Legs Syndrome. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-115-4_8
286. Higgins, A. (2010). Antidepressant-associated sexual dysfunction: impact, effects, and treatment. Drug Healthcare and Patient Safety. https://doi.org/10.2147/dhps.s7634
287. Hilderink, P. H. (2014). Medically unexplained symptoms in later life.
288. Hirose, S. (2003). The Causes of Underdiagnosing Akathisia. Schizophrenia Bulletin. https://doi.org/10.1093/oxfordjournals.schbul.a007027
289. Hirschfeld, R. M. A., Calabrese, J. R., Frye, M. A., Lavori, P. W., Sachs, G., Thase, M. E., & Wagner, K. D. (2007). Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening.. PubMed.
290. Holland, C. (2016). Emotional abuse. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198707707.003.0008
291. Hosseini, N., Moghaddam-Ahmadi, A., Dawarani, M. A. A., Bidaki, R., & TajikSafa, A. (2013). Prolonged Vertigo Associated with Nystagmus: an Organic or a Psychiatric Disorder? – Discussing a Case Report. Galen Medical Journal. https://doi.org/10.31661/gmj.v2i2.31
292. House, J. S. (1987). Chronic stress and chronic disease in life and work: Conceptual and methodological issues. Work & Stress. https://doi.org/10.1080/02678378708258494
293. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
294. Hyler, S. E., & Remien, R. H. (1998). Using Commercial Films to Teach About AIDS. Journal of Psychiatric Practice. https://doi.org/10.1097/00131746-199807000-00005
295. Hyun, J. S. (2014). AB54. Pathophysiology of premature ejaculation and serotonin. Translational Andrology and Urology. https://doi.org/10.3978/j.issn.2223-4683.2014.s054
296. Häuser, W., Dinkel, A., & Lahmann, C. (2012). Funktionelle gastrointestinale Störungen. Psychiatrie und Psychotherapie up2date. https://doi.org/10.1055/s-0032-1304958
297. Indusekhar, R., Usman, S. B., & O’Brien, S. (2006). Psychological aspects of premenstrual syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology. https://doi.org/10.1016/j.bpobgyn.2006.10.002
298. Insel, T. R. (2002). The Neurobiology of Affiliation: Implications for Autism. https://doi.org/10.1093/oso/9780195126013.003.0053
299. Iorga, M., Stârcea, I. M., Munteanu, M., & Sztankovszky, L.-Z. (2014). PSYCHOLOGICAL AND SOCIAL PROBLEMS OF CHILDREN WITH CHRONIC KIDNEY DISEASE.
300. Iroku-Malize, T., & Grissom, M. (2019). Violence and Public and Personal Health: Sexual Violence, Sexual Assault, and Sex Trafficking.. PubMed.
301. IsHak, W. W., Mikhail, A. A., Amiri, S. R., Berman, L., & Vasa, M. (2005). Sexual Dysfunction. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/foc.3.4.520
302. Issa, B. A. (2013). Prevalence and Correlates of Depressive Disorders among People Living with HIV/AIDS, in North Central Nigeria. Journal of AIDS & Clinical Research. https://doi.org/10.4172/2155-6113.1000251
303. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Psychedelics. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0606
304. İbiloğlu, A. O., Atlı, A., Kaya, M. C., Baran, A. S., & Sır, A. (2016). Psychogenic Gait Disorder After a Stressful Life Event: Case Report. Turkiye Klinikleri Journal of Case Reports. https://doi.org/10.5336/caserep.2015-46732
305. Jackowich, R. A., Pukall, C. F., & Goldstein, I. (2020). Persistent Genital Arousal Disorder. https://doi.org/10.1002/9781119482598.ch43
306. Jadresic, E. (2017). DEPRESIÓN POSPARTO EN EL CONTEXTO DEL HOSPITAL GENERAL. Revista Médica Clínica Las Condes. https://doi.org/10.1016/j.rmclc.2017.10.007
307. Janmohamed, S., & Bouloux, P.-M. (2016). Endocrinology of male sexual dysfunction. https://doi.org/10.1002/9781118746509.ch5
308. Jarząbek‐Bielecka, G., Mizgier, M., & Kędzia, W. (2019). … Not only a sexuological problem. Clinical and Experimental Obstetrics & Gynecology. https://doi.org/10.12891/ceog4656.2019
309. Jaskólska, M., Chylińska, M., Masiak, A., Czuszyńska, Z., Gałecka, K., Siemiński, M., Smoleńska, Ż., Ziętkiewicz, M., & Zdrojewski, Z. (2019). SAT0198 PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN PRIMARY SJOGREN’S SYNDROME – UNCOMMON OR UNDERESTIMATED PROBLEM?. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2019-eular.4851
310. Jenike, M. A. (2004). This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations. Obsessive-Compulsive Disorder.
311. Jiménez, D. E. A. (2020). El trastorno por consumo de alcohol como producto del conflicto intrapsíquico. Revista Torreón Universitario. https://doi.org/10.5377/torreon.v9i26.10261
312. Kanaly, K. A., & Berman, J. R. (2002). Sexual side effects of SSRI medications: potential treatment strategies for SSRI-induced female sexual dysfunction.. PubMed.
313. Kaplan, H. S. (1993). Post-ejaculatory pain syndrome. Journal of Sex & Marital Therapy. https://doi.org/10.1080/00926239308404893
314. Kapur, N., & Goldney, R. D. (2019). Psychiatric disorders and biological factors. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198791607.003.0005
315. Karageorgiou, I., Kokkinakis, S., Maliotis, N., Lionis, C., & Symvoulakis, E. K. (2021). Maximizing patient benefit through a reversed pathway from specialist to generalist: the case of chronic pain. Medicine and Pharmacy Reports. https://doi.org/10.15386/mpr-1873
316. Karatepe, H. T., Işık, H., Sayar, K., & Yavuz, F. (2010). Menstruation-related recurrent psychotic disorder: a case report. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. https://doi.org/10.5350/dajpn2010230409t
317. Kazymova, N., Kharlamenkova, N. Y., & Nikitina, D. A. (2019). Severe life events and their psychological consequences: loss or threat of loss of nearest. Vestnik Kostroma State University Series Pedagogy Psychology Sociokinetics. https://doi.org/10.34216/2073-1426-2019-25-2-96-101
318. Kelemen, A., & Juhos, V. (2024). Nôi epilepszia. 1. rész. Lege Artis Medicinae. https://doi.org/10.33616/lam.34.0281
319. Kelly, F. D. (2010). Adjustment Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0015
320. Kelly, M. M., & Phillips, K. A. (2023). Phenomenology and Epidemiology of Body Dysmorphic Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780190068752.013.3
321. Keren, M., Apter, A., Mani, A., & Tyano, S. (1991). [Neuropsychiatric symptoms in systemic lupus erythematosus].. PubMed.
322. Kessler, R. C., Amminger, G. P., Aguilar‐Gaxiola, S., Alonso, J., Lee, S., & st, T. B. (2007). Age of onset of mental disorders: a review of recent literature. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0b013e32816ebc8c
323. Kessler, T. M., Fowler, C. J., & Panicker, J. N. (2009). Sexual dysfunction in multiple sclerosis. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.9.3.341
324. Khullar, A., & Swainson, J. (2024). Update on Insomnia for Primary Care. Canadian Primary Care Today. https://doi.org/10.58931/cpct.2024.2336
325. Kibel, D., Laffont, I., & Liddle, P. F. (1993). The Composition of the Negative Syndrome of Chronic Schizophrenia. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.162.6.744
326. Kim, H. A., Bisdorff, A., Bronstein, A. M., Lempert, T., Rossi-Izquierdo, M., Staab, J. P., Strupp, M., & Kim, J. (2019). Hemodynamic orthostatic dizziness/vertigo: Diagnostic criteria. Journal of Vestibular Research. https://doi.org/10.3233/ves-190655
327. King, E. A., & Nepps, P. (1993). Obsessive-compulsive disorder in childhood: a behavioral approach to management.. PubMed.
328. Kinney, M., & Craig, J. (2015). Grand Rounds: An Update on Convulsive Status Epilepticus.. PubMed.
329. Kirilly, E., Gonda, X., Juhász, G., & Bagdy, G. (2013). Nem pszichiátriai gyógyszerek szorongást és depressziót kiváltó mellékhatásai | Anxiogenic and depressogenic side-effects of non-psychiatric drugs.
330. Klanšček, H. J., Zorko, M., Roškar, S., Bajt, M., & Kamin, T. (2010). Some Characteristics of Mental Health in the Slovene Population. DOAJ (DOAJ: Directory of Open Access Journals).
331. Klassen-Bolding, S., & Lenz, A. S. (2016). Post-traumatic Stress Disorder in Youth. https://doi.org/10.63134/mwtw7144
332. Knibb, J. A., & Hodges, J. R. (2005). Semantic Dementia: Losing the Meaning of Everything. Practical Neurology. https://doi.org/10.1111/j.1474-7766.2005.00316.x
333. Konez, O., Pascual-Castroviejo, I., Rocco, C. D., & Ruggieri, M. (2008). Sturge-Weber Syndrome. https://doi.org/10.1007/978-3-211-69500-5_10
334. Konuk, N., Öztürk, Ü., Karakuş, G., & Tamam, L. (2007). Postpartum Obsesif Kompulsif Bozukluk: Bir Gözden Geçirme. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology.
335. Kozian, R. (2019). Sexuelle Enthemmung bei Therapie mit Aripiprazol. Psychiatrische Praxis. https://doi.org/10.1055/a-0941-3874
336. Kreek, M. J. (2011). Extreme marginalization: addiction and other mental health disorders, stigma, and imprisonment. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2011.06152.x
337. Krieger, J. E., Rößner-Ruff, V., Friedrich, K., Penkov, C. A., Ziegenbein, M., Führmann, F., & Graef-Calliess, I. T. (2025). Male Depression – Are gender-related personality traits associated with the severity of depressive symptoms?. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2025.858
338. Krumholz, A., Sung, G., Fisher, R. S., Barry, E. F., Bergey, G. K., & Grattan, L. M. (1995). Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology. https://doi.org/10.1212/wnl.45.8.1499
339. Krystal, A. D., Edinger, J. D., & Wohlgemuth, W. K. (2013). Sleep and Circadian Rhythm Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt08
340. Kumar, A., & Arora, R. (2013). Medicinal Plants Effective In Treatment of Sexual Dysfunction: A Review. Journal of Medicinal Plants Studies.
341. Kumar, G. P., Krishna, P. Y., Manisha, D., Singh, G., Khushboo, A., & Ps, M. (2015). ROLE OF MANAS BHAVA IN THE ETIOPATHOGENESIS OF AMLAPITTA IN CONTEXT OF HYPERACIDITY.
342. Kumar, P., Bhaskar, M., & Soni, A. (2019). PRIMARY VERSUS SECONDARY PSYCHIATRIC DISORDERS: A TYPICAL CASE PRESENTATION. Indian Journal of Case Reports. https://doi.org/10.32677/ijcr.2019.v05.i02.016
343. Kumar, S., & Browne, M. O. (2003). What are the effects of drug treatments for panic disorder?. Evidence-Based Mental Health. https://doi.org/10.1136/ebmh.6.2.34
344. Kuntz, A., Karyoti, M., & Gothuey, I. (2019). [Adolescents and young adults with substance abuse and comorbid psychiatric disorders : which treatment ?]. PubMed.
345. Kushon, D., McCown, W., Ditre, C. M., Posa, J., Hines, J., & Williams, L. (2008). Stressful Life Events and Alopecia Areata. Loss Grief & Care. https://doi.org/10.1300/j132v07n03_08
346. Landa-Contreras, E., Martín-Orozco, U. J. F.-C., Alvites-Ahumada, M. P., Fortes-Álvarez, J. L., & Perez-López, M. D. L. D. (2015). Orgasmos a repetición asociados a ISRS: reporte de un caso y revisión de la literatura.
347. Landers, D. M. (2002). Anorexia in Exercise and Sport. Medicine & Science in Sports & Exercise. https://doi.org/10.1097/00005768-200205001-01795
348. Landolfi, M., Parise, V. F., Balletta, G., & Manna, G. L. (2011). Recovery Versus Remission in Schizophrenia and Related Persistent Psychotic Disorders: no Contrasting but Complementary Models. European Psychiatry. https://doi.org/10.1016/s0924-9338(11)73091-7
349. Leal, C. C. S., & Valença, A. M. (2020). Alleged amnesia in sexual crime. Jornal Brasileiro de Psiquiatria. https://doi.org/10.1590/0047-2085000000281
350. Ledezma, C., Soto, K., & Suárez, M. I. (2015). Depresión en el adulto mayor en Costa Rica: un problema social. Revista Hispanoamericana de Ciencias de la Salud.
351. Lee, H.-Y., & Ham, B. (2013). Stress and mental illness. Journal of Korean Medical Association. https://doi.org/10.5124/jkma.2013.56.6.471
352. Leiblum, S. R. (2003). Arousal disorders in women: complaints and complexities. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2003.tb05392.x
353. Leiblum, S. R., & Goldmeier, D. (2008). Persistent Genital Arousal Disorder in Women: Case Reports of Association with Anti-Depressant Usage and Withdrawal. Journal of Sex & Marital Therapy. https://doi.org/10.1080/00926230701636205
354. Leitão, F., Pinho, S. A., Freitas, J., & Coutinho, F. (2024). Review of Delusional Jealousy and Its Association with Sexual Dysfunctions. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1582
355. Lema, R., & Ricci, P. (2006). ATRAPAMIENTO DEL NERVIO PUDENDO: UN SÍNDROME POR CONOCER. Revista chilena de obstetricia y ginecología. https://doi.org/10.4067/s0717-75262006000300011
356. Lemogne, C., Pitron, Jy, R., Limosin, F., & Cathébras, P. (2019). What attitude towards a patient with somatoform disorder?. PubMed.
357. Leoni, M. C., Pizzo, D., Rundo, B., Tasso, G., & Marchi, A. (2009). Atassia in ex-prematuro: un caso pediatrico. Bollettino della Società Medico Chirurgica di Pavia. https://doi.org/10.6092/2039-1404.122.404
358. Levine, L. A. (2013). The clinical and psychosocial impact of Peyronie's disease.. PubMed.
359. Levy, A. M. (1986). Psychopathological Responses to Threatened Custody Loss. The Journal of Psychiatry & Law. https://doi.org/10.1177/0093185386014003-407
360. Li, G., Gs, V., & IuI, P. (1988). Sexual disorders in women with slowly progressing schizophrenia. Zhurnal Nevropatologii I Psikhiatrii Imeni S S Korsakova.
361. Lin, L., Ferraz‐de‐Souza, B., & Achermann, J. C. (2007). Genetic Disorders Involving Adrenal Development. KARGER eBooks. https://doi.org/10.1159/000111056
362. Linde (2007). Chronisches Erschöpfungssyndrom – eine funktionelle Störung. Therapeutische Umschau. https://doi.org/10.1024/0040-5930.64.10.567
363. Liu, T., Song, X.-M., Chen, G., & Zheng, X. (2013). [Violent behavior in people with schizophrenia: a review].. PubMed.
364. Loconte, S. (2019). Primary fibromyalgia syndrome: A new holistic approach [abstract]. Journal of Ozone Therapy. https://doi.org/10.7203/jo3t.3.4.2019.15526
365. Luke, M., & Stopa, L. (2009). Psychological theories of the self and their application to clinical disorders. Routledge eBooks. https://doi.org/10.4324/9780203878644-7
366. Lupu, S., Bratu, O. G., Mirela, D., Bungău, S., Maghiar, O., Maghiar, T., Scârneciu, C. C., & Scârneciu, I. (2021). Genital self‑mutilation: A challenging pathology (Review). Experimental and Therapeutic Medicine. https://doi.org/10.3892/etm.2021.10564
367. L�pine, J.-P., & Briley, M. (2004). The epidemiology of pain in depression. Human Psychopharmacology Clinical and Experimental. https://doi.org/10.1002/hup.618
368. Macneil, C., Hasty, M., Conus, P., Berk, M., & Scott, J. (2009). Social rhythm regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511757389.008
369. Macrì, F., Minichino, A., Campi, S., Marino, M., Pannese, R., Michele, F. D., Capra, E., Trabucchi, G., & Bersani, F. S. (2013). [Chronic conversion somatic disorder: a case report].. PubMed. https://doi.org/10.1701/1241.13708
370. Madan, A., Frueh, B. C., Fowler, J. C., Stomberg, S., Bradshaw, M. R., Kelly, K. R., Weinstein, B., Luttrell, M., Danner, S. G., & Beidel, D. C. (2020). “Operator syndrome”: A unique constellation of medical and behavioral health-care needs of military special operation forces. The International Journal of Psychiatry in Medicine. https://doi.org/10.1177/0091217420906659
371. Madhavan, J. (2017). Ayurvedic Approach to Alcohol Withdrawal Syndrome. International Journal of Complementary & Alternative Medicine. https://doi.org/10.15406/ijcam.2017.07.00226
372. Maguire, G. A. (2002). Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences.. PubMed.
373. Mahdy, D. S., Ali, E., Rageh, T. S., & Mageed, A. A. A. (2018). Erectile dysfunction in cerebrovascular stroke patients. Journal of Current Medical Research and Practice. https://doi.org/10.4103/jcmrp.jcmrp_150_18
374. Maj, M. (2023). Understanding depression beyond the “mind‐body” dichotomy. World Psychiatry. https://doi.org/10.1002/wps.21142
375. Makaricheva, E. V., Mendelevich, В. D., & Eremkina, V. I. (1995). Sexologic peculiarities of patients with functional disorders of the menstrual cycle and sterility. Kazan medical journal. https://doi.org/10.17816/kazmj90448
376. Maksimova, M. Y., & Kotlyar, Y. А. (2024). Kleine—Levin syndrome. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro2024124071169
377. Malenfant, M., Tremblay, S., Laurin, D., & Lefèbvre, J. (2008). L'utilisation du citalopram pour traiter l'agitation et les symptômes psychotiques chez les patients souffrant de démence.
378. Maltseva, L., Lisnycha, V., Kobelatskyy, Y., & Kazimirova, N. (2021). Вплив додаткової нейропротекції Гліатиліном на перебіг септичного процесу і вираженість енцефалопатії в структурі синдрому поліорганної недостатності. EMERGENCY MEDICINE. https://doi.org/10.22141/2224-0586.17.2.2021.230634
379. Mameniškienė, R., Bast, T., Bentes, C., Canevini, M. P., Dimova, P., Granata, T., Høgenhaven, H., Jakubi, B. J., Marusič, P., Melikyan, G., Michelucci, R., Мukhin, К. Y., Oehl, B., Ragona, F., Rossetti, A. O., Rubboli, G., Schubert‐Bast, S., Stephani, U., Strobel, J., ... Wolf, P. (2011). Clinical course and variability of non-Rasmussen, nonstroke motor and sensory epilepsia partialis continua: A European survey and analysis of 65 cases. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02974.x
380. Mandos, L. A., PharmD, Reinhold, J. A., Bcps, Bcpp, & Rickels, K. (2009). Achieving Remission in Generalized Anxiety Disorder.
381. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
382. Manniche, C., Hauge, E., Voss, A., Mašić, D., Johannsen, F. E., Johannsen, F. E., Voss, A., Mašić, D., Mašić, D., Voss, A., & Johannsen, F. E. (2018). Patient med rygsmerter. Research Portal Denmark.
383. Manohar, S., Koolwal, A., & Rao, T. S. (2019). Sex and Depression. Journal of Psychosexual Health. https://doi.org/10.1177/2631831818821532
384. Mantere, O., & Vuorilehto, M. (2015). [Recognition of mood disorders].. PubMed.
385. Maramis, M. M. (2009). Mengenal Gangguan Mood pada Perempuan.
386. Markham, R. A., & Watts, S. (2005). Etiology of Depression in Children.. Journal of instructional psychology.
387. Marks, D. J., Trampush, J. W., & Chacko, A. (2010). Attention deficit hyperactivity disorder in children and adolescents. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511674815.008
388. Martı́n, M. A., Lucía, A., Arenas, J., & Andreu, A. L. (2014). Glycogen Storage Disease Type V.
389. Mazzoni, P., Kimhy, D., Khan, S., Posner, K., Maayan, L., Eilenberg, M., Walsh‐Messinger, J., Kestenbaum, C. J., & Corcoran, C. M. (2009). Childhood Onset Diagnoses in a Case Series of Teens at Clinical High Risk for Psychosis. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2008.0105
390. McAnally, H. B. (2018). A Keynesian (demand reduction) Approach to the Opioid Epidemic. Pain Management. https://doi.org/10.2217/pmt-2018-0003
391. McCabe, M. P., Hertlein, K. M., & Davis, E. (2019). Female Orgasmic Disorder. Routledge eBooks. https://doi.org/10.4324/9780429297403-9
392. McDaid, C., Trowman, R., Golder, S., Hawton, K., & Sowden, A. (2011). reviewfor people bereaved through suicide: systematic.
393. McGhie-Fraser, B., McLoughlin, C., Lucassen, P., Ballering, A., Dulmen, S. V., Brouwers, E., Stone, J., & Hartman, T. O. (2024). Measuring persistent somatic symptom related stigmatisation: Development of the Persistent Somatic Symptom Stigma scale for Healthcare Professionals (PSSS-HCP). Journal of Psychosomatic Research. https://doi.org/10.1016/j.jpsychores.2024.111689
394. McKnight, R., Price, J., & Geddes, J. (2019). People presenting with physical disorder. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0027
395. McMahon, C. G. (2017). Ejaculatory disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199659579.003.0105
396. Mearin, F., Ciriza, C., Mínguez, M., Rey, E., Mascort, J., Peña, E. D. L., Cañones, P., & Júdez, J. (2016). Clinical Practice Guideline: Irritable bowel syndrome with constipation and functional constipation in the adult. Revista Española de Enfermedades Digestivas. https://doi.org/10.17235/reed.2016.4389/2016
397. Medina, S., & Fernando, D. (2019). Caso Christopher : El deseo, de deseo imposible en la neurosis obsesiva..
398. Mehlum, L. (2006). Trauma as a life event and its impact on suicidal behaviour. Psychiatria Danubina.
399. Meltzer‐Brody, S., & Leserman, J. (2011). Psychiatric Comorbidity in Women with Chronic Pelvic Pain. CNS Spectrums. https://doi.org/10.1017/s1092852912000156
400. Menchete, T. T., Bertoli, R. S., Loureiro, A. A., Silva, A. C. J. D. S. R. E., Dach, F., Troncon, J. K., Cantelli, D. A. L., & Lara, L. A. D. S. (2023). Management of persistent genital arousal disorder: A case report. Global Translational Medicine. https://doi.org/10.36922/gtm.2341
401. Menezes, M. C. D. C., Gonçalves, L. G. V., Chaves, S. C. D. S., Jaime, T. F. M., Oliveira, I. C. Z., Sobrinho, K. D. L., Oliveira, L. L. D., Araújo, J. V. L. D., Gurian, F. G., Soares, I. L. T., Nero, L. D., Pereira, P. H. D. O., Moraes, F. D. C., & Teixeira, G. P. (2023). MAIN CAUSES OF INTENTIONAL ACCIDENTS IN PEDIATRICS AND CLINICAL MANIFESTATIONS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593712308095
402. Meston, C. M., Freihart, B. K., & Stanton, A. M. (2023). Sexual Dysfunction. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780197542521.003.0017
403. Meston, C. M., Levin, R. J., Sipski, M. L., Hull, E. M., & Heiman, J. R. (2004). Women's orgasm.. PubMed.
404. Mevorach, T., Stern, B., Fennig, S., Apter, A., & Benaroya-Milshtein, N. (2019). [EXCORIATION (SKIN-PICKING) DISORDER].. PubMed.
405. Meyer, J. S., & Hamel, A. F. (2014). Models of Stress in Nonhuman Primates and Their Relevance for Human Psychopathology and Endocrine Dysfunction. ILAR Journal. https://doi.org/10.1093/ilar/ilu023
406. Michael, A., & Andrews, S. C. (2002). Paroxetine-Induced Vaginal Anaesthesia. Pharmacopsychiatry. https://doi.org/10.1055/s-2002-33196
407. Michel, B. (2020). Posttraumatic stress disorder concerning the end of the covid-19 lockdown: A mini review. Archives of Depression and Anxiety. https://doi.org/10.17352/2455-5460.000044
408. Miettinen, O. S., & Flegel, K. M. (2003). Elementary concepts of medicine: VII. Course of illness: manifestations, complications, outcome. Journal of Evaluation in Clinical Practice. https://doi.org/10.1046/j.1365-2753.2003.00420.x
409. Miller, B. L., Cummings, J. L., McIntyre, H., Ebers, G. C., & Grode, M. (1986). Hypersexuality or altered sexual preference following brain injury.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.49.8.867
410. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
411. Millner, V. S., & Ullery, E. K. (2002). A Holistic Treatment Approach to Male Erectile Disorder. The Family Journal. https://doi.org/10.1177/106648002236768
412. Mirawati, D. K. (2018). Managing antiepileptic drug, Starting, Changing and Stopping AED’s.
413. Miyake, K., Takaki, M., Sakamoto, S., Kawada, K., Inoue, S., & Yamada, N. (2018). Restless Genital Syndrome Induced by Milnacipran. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000279
414. Molière, F. (2014). Comorbidités psychiatriques et résistance thérapeutique. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.052
415. Montejo, Á. L., Montejo, L., & Baldwin, D. S. (2018). The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management. World Psychiatry. https://doi.org/10.1002/wps.20509
416. Montejo, Á. L., Montejo, L., & Navarro-Cremades, F. (2015). Sexual side-effects of antidepressant and antipsychotic drugs. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000198
417. Montgomery, S., Bebbington, P., Cowen, P. J., Deakin, J., Freeling, P., Hallström, C., Katona, C., King, D. S., Leonard, B., Levine, S., Phanjoo, A. L., Peet, M., Thompson, C. M., & Thompson, C. M. (1993). Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology. Journal of Psychopharmacology. https://doi.org/10.1177/0269881193007001041
418. Moraiti, V., & Porfyri, G. N. (2024). Schizophrenia and Risk of Dementia: A Literature Review.. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1583
419. Moret, C., Isaac, M., & Briley, M. (2008). Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors. Journal of Psychopharmacology. https://doi.org/10.1177/0269881108093582
420. Morgan, R. O., Pendleton, N., Clague, J., & Horan, M. (1997). Older people's perceptions about symptoms.. PubMed.
421. Morrell, M. J. (1991). Sexual Dysfunction in Epilepsy. Epilepsia. https://doi.org/10.1111/j.1528-1157.1991.tb05891.x
422. Moscarello, R. (1991). Posttraumatic Stress Disorder After Sexual Assault: Its Psychodynamics and Treatment. Journal of the American Academy of Psychoanalysis. https://doi.org/10.1521/jaap.1.1991.19.2.235
423. Mosolov, S. (2020). Diagnosis and Treatment of Depression in Patients with Schizophrenia. Consortium Psychiatricum. https://doi.org/10.17650/2712-7672-2020-1-2-29-42
424. Moudden, S. E., Chaouki, S., Abourazzak, S., & Hida, M. (2023). RETT SYNDROME: A CASE REPORT. International Journal of Advanced Research. https://doi.org/10.21474/ijar01/17850
425. Moura, G. S., Neves, L. M. T., Giorelli, A. S., Florido, P., & Gomes, M. D. M. (2013). Transtornos do sono: visão geral Sleep disorders: overview.
426. Mucci, A., Bucci, P., Giordano, G. M., Brando, F., & Galderisi, S. (2021). Apathy in schizophrenia: assessment in clinical settings and overlap with other dimensions of impairment. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.159
427. Munir, S., & Takov, V. (2021). Generalized Anxiety Disorder. StatPearls.
428. Munir, S., Takov, V., & Coletti, V. A. (2021). Generalized Anxiety Disorder (Nursing).
429. Murty, V. L., Baid, G. C., Sharma, S., Singh, S. K., Lath, V., & Jena, P. (2023). Obstructive Sleep Apnea: A Prosthodontist’s Viewpoint. Scholars Journal of Dental Sciences. https://doi.org/10.36347/sjds.2023.v10i05.005
430. Musálek, M. (2011). Pathologisches Spielen: Impulskontrollstörung oder Sucht?. Suchttherapie. https://doi.org/10.1055/s-0031-1284655
431. Mut, E. A., Pălădoiu, C., & Stănescu, M. (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
432. Müller, A. (2020). Mental health disorders: prevalent but widely ignored in academia?. The Journal of Physiology. https://doi.org/10.1113/jp279386
433. Münster, T., & Tzabazis, A. (2013). Somatische Intervention und Demenz - Einfluss von Chirurgie und Anästhesie auf kognitive Funktionen. PSYCH up2date. https://doi.org/10.1055/s-0033-1343131
434. Na, I., & Volel, B. A. (2002). [Clinical aspects of "folie du doute"].. PubMed.
435. Nabelek, L., Vongrej, J., & Demianova, J. (2007). Schizophrenia research: Ethical questions. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2007.01.1191
436. Nadeem, Z., McIntosh, A. M., & LAWRIE, S. M. (2004). Schizophrenia. Evidence-Based Mental Health. https://doi.org/10.1136/ebmh.7.1.2
437. Nagaraj, A. K. M., Pai, N., Nanjegowda, R. B., Rajagopal, R., Shivarudrappa, N. K. M., & Siddika, N. (2009). Etiology and management of sexual dysfunction. Online Journal of Health and Allied Sciences.
438. Nakata, C., Nara, K., Kinoshita, F., Kikuchi, K., & Asai, M. (2015). [Alcohol withdrawal syndrome showing various progress: A case report].. PubMed.
439. Narang, T., Garima, & Singh, S. M. (2016). Psychosexual disorders and dermatologists. Indian Dermatology Online Journal. https://doi.org/10.4103/2229-5178.182349
440. Naranđa, F. S. (2019). Značaj Empty selle u procjeni funkcije hipofize.
441. Nasreen, S. Z. A. (2019). Symptoms of Menopause. IntechOpen eBooks. https://doi.org/10.5772/intechopen.88572
442. Nava, G. M. (2018). Depression: From Sorrow to Melancholia. Scholarly Journal of Psychology and Behavioral Sciences. https://doi.org/10.32474/sjpbs.2018.01.000106
443. Navarra, C. H., Losada, L. L., & Piqueras, J. P. (1988). Ingreso psiquiátrico muy breve. Características en el Hospital Psiquiátrico de Bétera .. Revista de la Asociación Española de Neuropsiquiatría..
444. Nicolson, G. L., Nasralla, M. Y., Haier, J., & Nicolson, N. L. (1999). GULF WAR ILLNESSES: ROLE OF CHEMICAL, RADIOLOGICAL AND BIOLOGICAL EXPOSURES.
445. Nivoli, G., Lorettu, L., Veneto, L. I., Milia, P., Nivoli, L., & Nivoli, A. (2006). Problemi gestionali delle gravi manifestazioni aggressive : Criminalità e spettro dell'umore. https://doi.org/10.1400/91497
446. Niwiński, P., Remberk, B., Rybakowski, F., & Rokicki, D. (2020). Psychiatric Symptoms as the First or Solitary Manifestation of Somatic Illnesses: Hyperammonaemia Type II. Neuropsychobiology. https://doi.org/10.1159/000508679
447. Nizamie, A., Sengupta, U., Mishra, B. R., Praharaj, S. K., & Nizamie, S. H. (2010). Alka Nizamie;Uma Sengupta;Biswa Ranjan Mishra;Samir Kumar Praharaj;S. Haque Nizamie. Acta Neurologica Taiwanica. https://doi.org/10.29819/ant.201003.0008
448. Nițescu, D., Nicolau, A., Caraiola, S., Predețeanu, D., Ionescu, R., & Tănăsescu, C. (2011). Neuromyelitis optica--complication or comorbidity in primary Sjögren's syndrome?. PubMed.
449. Nusbaum, M. (2002). Erectile dysfunction: prevalence, etiology, and major risk factors.. PubMed.
450. Oh, S.-H. (2019). 12 - CAN RORSCHACH DIFFERENTIATE BIPOLAR DISORDER FROM DEPRESSIVE DISORDER? : COMPARISON OF RORSCHACH SCORES BETWEEN BIPOAR DEPRESSION AND UNIPOLAR DEPRESSION. https://doi.org/10.26226/morressier.5d1a038757558b317a13f97e
451. Ohayon, M. M., Dauvilliers, Y., & Milesi, C. (2016). [DEFINITIONS AND EPIDEMIOLOGY OF EXCESSIVE SLEEPINESS].. HAL (Le Centre pour la Communication Scientifique Directe).
452. Okechukwu, C. E. (2021). Neuropsychopathology of gambling disorder. MGM Journal of Medical Sciences. https://doi.org/10.4103/mgmj.mgmj_32_21
453. Okuniewska, A., Walczuk, B. I., Czubek, M., & Biernat, W. (2011). Recurrent Deep Ulcers Resembling Rare Cancers as a Form of Factitious Disorder. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-1027
454. Olmedo, A., & Rolando, M. (2015). Informe psicológico pericial: situación de violencia intrafamiliar, “maltrato física, psicológica y sexual”, grado de afectación psicológico..
455. Omran, S., Reza, M., Bali, B., & Kazem, M. (2010). A Case Report of A 2.5-Year-Old Girl with Angelman Syndrome (AS). Iranian journal of child neurology.. https://doi.org/10.22037/ijcn.v3i4.1539
456. Ong, L. T. C., Galambos, G., & Brown, D. A. (2017). Primary Sjogren’s Syndrome Associated With Treatment-Resistant Obsessive–Compulsive Disorder. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2017.00124
457. Ortiz, S. R., Carrillo-Albornoz, E. J. O., & Coque, J. A. R. (2016). La intervención policial con sujetos confuso-agitados: El denominado “delirio agitado”. Cuadernos de la Guardia Civil: Revista de seguridad pública.
458. Os, J. V., Praag, H. M. V., & Kloet, E. R. D. (2004). Stress, the brain and depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544422.010
459. Oshagh, M., Bahramnia, F., Aminsharifi, A., Fallahzadeh, M. H., & Ghodrati, P. (2014). Effects of maxillary expansion and placebo effect of appliances on nocturnal enuresis – preliminary results. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. https://doi.org/10.5173/ceju.2014.01.art11
460. Osterman, J. E., Erdos, B. Z., Oldham, M., & Ivkovic, A. (2010). Antidepressant Treatments in PTSD. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-435-7_7
461. Ostrowski, M., & Mietkiewicz, M. (2015). Approach of the sexuality of Alzheimer's disease patients according to caregivers’ guides approach. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2015.0580
462. Otaola, S. P. (1999). Evolución y pronóstico de la discapacidad en el paciente hemipléjico.
463. Otsuka, K., Kato, S., Abe, T., SUGIYAMA, H., Watanabe, Y., Kobayashi, T., & Okajima, Y. (2002). [Classification of long-term clinical course of 'atypical psychosis': a 20-year follow-up study at a medical school hospital].. PubMed.
464. Ownby, R. L. (2006). Medication adherence and cognition. Medical, personal and economic factors influence level of adherence in older adults.. PubMed.
465. Ozdemir, D., & Sahni, S. (2019). Conversion Disorder (Functional Neurological Symptom Disorder) Masquerading as Multiple Sclerosis: A Case Report. Cureus. https://doi.org/10.7759/cureus.4893
466. Pablos, E. G., & Andres, R. S. (2005). Un caso de ageusia inducido por venlafaxina.
467. Page, C. E., Soreth, B., Metcalf, C. A., Johnson, R. L., Duffy, K. A., Sammel, M. D., Loughead, J., & Epperson, C. N. (2024). Natural vs. Surgical Postmenopause and Psychological Symptoms Confound the Effect of Menopause on Executive Functioning Domains of Cognitive Experience. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/appi.focus.23021034
468. Palmer, B. F. (1999). Sexual Dysfunction in Uremia. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.v1061381
469. Paloneva, J., Autti, T., Hakola, P., & Haltia, M. (2015). Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy.
470. Pantoularis, I., Garyfallos, G., Lobtzianidou, M., Livanos, A., Dasoukis, I., & Adamopoulou, A. (2008). Axis I-Axis II comorbidity of borderline personality disorder: gender-related differences. Annals of General Psychiatry. https://doi.org/10.1186/1744-859x-7-s1-s226
471. Papazian, Ó., & Alfonso, I. (2002). Polirradiculoneuropatías autoinmunes agudas. Revista de Neurología. https://doi.org/10.33588/rn.3402.2001337
472. Paradela, E. M. P. (2011). Depressão em idosos. Revista Hospital Universitário Pedro Ernesto (TÍTULO NÃO-CORRENTE). https://doi.org/10.12957/rhupe.2011.8850
473. Parano, E., Pappalardo, X. G., Pavone, P., Ruggieri, M., & Cavallaro, S. (2016). Child Abuse Syndrome (CAS): A Newly Recognized Distinct Entity. The Open Neurology Journal. https://doi.org/10.2174/1874205x01610010030
474. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
475. Paredes, G., Rondón-Carvajal, J., Vielma, M., & Andrade, M. M. (2006). Estudio preliminar de la profilaxis de la epilepsia en acúmulos, con midazolam. MedULA: revista de la Facultad de Medicina.
476. PARISER, S. F., Nasrallah, H. A., & Gardner, D. L. (1997). Postpartum Mood Disorders: Clinical Perspectives. Journal of women's health. https://doi.org/10.1089/jwh.1997.6.421
477. Patel, J. P., Edwards, A. D., & Azzopardi, D. (1997). Prevention of acquired neurological impairment in the perinatal period. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.63.2008.34s
478. Paw, H., & Shulman, R. (2014). Management of status epilepticus. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781316182673.042
479. Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995). Residual symptoms after partial remission: an important outcome in depression. Psychological Medicine. https://doi.org/10.1017/s0033291700033146
480. Pedroso, A. P. F., Tomasetti, C. S., Coelho, C. I., Pinho, E. C. D. A., & Oliani, S. M. (2018). Stress em renais crônicos: treino de relaxamento amenizando a sessão de hemodiálise. Revista Terra & Cultura: Cadernos de Ensino e Pesquisa.
481. Perington, M. R., Smith, C. A., & Schillerstrom, J. E. (2019). Decisional Capacity and Personality Disorders: Substantially Unable or Substantially Unwilling?. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.14219
482. Peyton, D. L. (2007). La atención de los síntomas psicológicos durante el climaterio femenino. DOAJ (DOAJ: Directory of Open Access Journals).
483. Peyton, D. L. (2010). La atención de los sintomas psicológicos durante el climaterio femenino. DOAJ (DOAJ: Directory of Open Access Journals).
484. Peña, D. A., Pérez, M. L., & Pinzón, L. F. C. (2014). Línea de investigación psicología clínica y de la salud..
485. Peña, M. A. M. (2013). Síndrome de sobreentrenamiento. IATREIA.
486. Piggott, T. A., Duran, A. N., Jalnapurkar, I., Kimm, T., Linscheid, S., & Allen, M. (2019). Sex Differences in Anxiety Disorders. https://doi.org/10.1093/oxfordhb/9780190649739.013.21
487. Pivonello, R., Neggers, S. J. C. M. M., & Imran, S. A. (2023). Psychopathology in Acromegaly—Real and Perceived. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad237
488. Piwuna, C. G., Makput, D. M., & Wakil, M. A. (2015). Persistent delusional disorder in a 32 year old male. Highland Medical Research Journal.
489. Poeck, K. (2002). Zur neurologischen Begutachtung nach „HWS-Schleudertrauma”. Aktuelle Neurologie. https://doi.org/10.1055/s-2002-32913
490. Politis, M., Wu, K., Molloy, S., Bain, P. G., Chaudhuri, К. R., & Piccini, P. (2010). Parkinson's disease symptoms: The patient's perspective. Movement Disorders. https://doi.org/10.1002/mds.23135
491. Pompignac, M. (2015). Cas de dépression post-partum chez une femelle orang-outan. Revue de primatologie. https://doi.org/10.4000/primatologie.2169
492. Pontari, M. A. (2020). Definition and epidemiology of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). https://doi.org/10.5680/lhuii000050
493. Pontius, A. A. (1984). Specific Stimulus-Evoked Violent Action in Psychotic Trigger Reaction: A Seizure-like Imbalance between Frontal Lobe and Limbic Systems?. Perceptual and Motor Skills. https://doi.org/10.2466/pms.1984.59.1.299
494. Pontius, A. A. (1988). Limbic System-Frontal Lobes' Role in Subtypes of “Atypical Rape”. Psychological Reports. https://doi.org/10.2466/pr0.1988.63.3.879
495. Pontius, A. A. (1993). NEUROPSYCHIATRIC UPDATE OF THE CRIME "PROFILE" AND "SIGNATURE" IN SINGLE OR SERIAL HOMICIDES: RULE OUT LIMBIC PSYCHOTIC TRIGGER REACTION. Psychological Reports. https://doi.org/10.2466/pr0.1993.73.3.875
496. Pontius, A. A. (1993). Neuropsychiatric Update of the Crime “Profile” and “Signature” in Single or Serial Homicides: Rule out Limbic Psychotic Trigger Reaction<sup>1</sup>. Psychological Reports. https://doi.org/10.1177/00332941930733pt125
497. Popa, T., & Delcea, C. (2019). Voyeurism and Scopophilia. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.11.121
498. Potvin, O., Hudon, C., Grenier, S., & Préville, M. (2010). Non-essential symptoms of depression and cognitive impairment no dementia (CIND) in community-dwelling elders without dysphoria or anhedonia. International Psychogeriatrics. https://doi.org/10.1017/s1041610210001419
499. Powlishta, K. K., Storandt, M., Mandernach, T., Hogan, E., Grant, E., & Morris, J. C. (2004). Absence of Effect of Depression on Cognitive Performance in Early-Stage Alzheimer Disease. Archives of Neurology. https://doi.org/10.1001/archneur.61.8.1265
500. Pozzoli, S., Altamura, A. C., & Bosi, M. (2006). Il trattamento a lungo termine della Depressione Unipolare: focus sulla terapia con Venlafaxina RP. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
501. Praag, H. M. V. (1998). Anxiety and increased aggression as pacemakers of depression. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1998.tb05971.x
502. Prabhakar, D., & Balon, R. (2010). How Do SSRIs Cause Sexual Dysfunction? Understanding Key Mechanisms Can Help Improve Patient Adherence, Prognosis. Current psychiatry.
503. Pradeep, V. A. J. (2013). Study on Neurological Soft Signs in patients with ObsessiveCompulsive Disorder..
504. Prager, L. M. (2009). Depression and Suicide in Children and Adolescents. Pediatrics in Review. https://doi.org/10.1542/pir.30.6.199
505. Praško, J., Raszka, M., & Pastucha, P. (2009). Dissociative Disorders - Clinical Manifestation and Management. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70376-1
506. Prigatano, G. P., Hendin, B., & Heiserman, J. E. (2014). Denial or unawareness of cognitive deficit associated with multiple sclerosis? A case report. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803395.2014.890700
507. Puigcerver, A., & Arenas, M. C. (2009). Diferencias entre hombres y mujeres en los trastornos de ansiedad: una aproximación psicobiológica. Escritos de Psicología / Psychological Writings. https://doi.org/10.24310/espsiescpsi.v3i1.13331
508. Pyszora, N., Fahy, T., & Kopelman, M. D. (2014). Amnesia for violent offenses: factors underlying memory loss and recovery.. PubMed.
509. Pérez, C. (2021). Encefalitis miálgica o síndrome de fatiga crónica, implicaciones en su abordaje en las unidades del dolor en la era post-COVID. Revista de la Sociedad Española del Dolor. https://doi.org/10.20986/resed.2021.3960/2021
510. Pérez, J. M., Prudencio, S. F., Navarro, A. G., Comi, M. L., & Pascual, R. A. (2013). Evolución y seguimiento de los trastornos del espectro autista. Revista de Neurología. https://doi.org/10.33588/rn.56s01.2012655
511. Qureshi, M. A., & Wasti, S. A. (2014). Lay-off Survivor Sickness Syndrome (Investigating the Lasting Impact on Performance of Survivors in the Context of Age and Gender in Private Sector Organizations of Pakistan). International Journal of Human Resource Studies. https://doi.org/10.5296/ijhrs.v4i3.6078
512. Rabinerson, D., Ben‐Shitrit, G., & Glezerman, M. (2011). [Lethal sex].. PubMed.
513. Racciatti, D., Barberio, A., Vecchiet, J., & Pizzigallo, E. (1999). Clinical and Pathogenetical Characterization of 238 Patients of a Chronic Fatigue Syndrome Italian Center. Journal of Chronic Fatigue Syndrome. https://doi.org/10.1300/j092v05n03_05
514. Rakofsky, J. J., & Dunlop, B. W. (2014). Treating Bipolar Mania in the Outpatient Setting: Enlist the Help of Family, Employ Evidence-Based Pharmacologic and Psychotherapeutic Strategies. Current psychiatry.
515. Ramakrishnan, D. S. (2018). POEMS Syndrome: An Atypical Presentation. Journal of Medical Science And clinical Research. https://doi.org/10.18535/jmscr/v6i7.185
516. Ramos, I. M., Ferraz, I., Coelho, T., & Mota, M. (2015). First Faster Then Slower. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)32100-3
517. Rana, N., Drake, M. J., Rinko, R., Dawson, M., & Whitmore, K. (2018). The fundamentals of chronic pelvic pain assessment, based on international continence society recommendations. Neurourology and Urodynamics. https://doi.org/10.1002/nau.23776
518. Rao, T. S., & Kumar, M. A. (2008). Agenda for specialty section in addiction medicine. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.44741
519. Rao, T. S., Maheshwari, S., George, M., Chandran, S., Manohar, S., & Rao, S. S. (2018). Psychosocial interventions for sexual dysfunction in addictive disorders. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_37_18
520. Rapkin, A. J., Korotkaya, Y., & Taylor, K. C. (2019). &lt;p&gt;Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives&lt;/p&gt;. Open Access Journal of Contraception. https://doi.org/10.2147/oajc.s183193
521. Rasgon, N., Shelton, S., & Halbreich, U. (2005). Perimenopausal Mental Disorders: Epidemiology and Phenomenology. CNS Spectrums. https://doi.org/10.1017/s1092852900023166
522. Raturi, P., Bartwal, V., & Prajapati, A. (2021). EFFECT OF SATVAVAJAYCHIKITSA (COUNSELLING AND ASSURANCE) AND SHIRODHARA IN THE MANAGEMENT OF PSYCHOGENIC ERECTILE DYSFUNCTION: A CASE STUDY. International Ayurvedic Medical Journal. https://doi.org/10.46607/iamj3509112021
523. Rayfield, A., Thomas, C., & Borovicka, M. C. (2014). Management of behavioral and psychological symptoms of dementia: The role of mood stabilizers. Mental Health Clinician. https://doi.org/10.9740/mhc.n204493
524. Rebolleda, J. G. (2013). Estudio de los síntomas somáticos asociados a los trastornos depresivos y de ansiedad en una población de atención primaria.
525. Reinares, M., Martínez‐Arán, A., & Vieta, E. (2019). Psychoeducation for Patients and Family Members. Cambridge University Press eBooks. https://doi.org/10.1017/9781108589802.004
526. Reséndiz-Aparicio, J. C., Pérez-García, J. C., Olivas‐Peña, E., García-Cuevas, E., Roque-Villavicencio, Y. L., Hernández-Hernández, M., Castro-Macías, J. I., & Rayo-Mares, J. D. (2023). Guía clínica. Definición y clasificación de la epilepsia. DELETED. https://doi.org/10.24875/rmn.m19000052
527. Rj, M., Ha, L., Loredo, D., Dj, C., Roiter, H. G., Bauducco, G., Bilbao, L. S., Brousset, P., D'Avila, A., Me, F., Herreros, S., Luchino, O., & Nuciforo, F. (2007). [Psycho-pathological risk factor of arterial disease (prevalence, superposition or vinculation with other factors)].. PubMed.
528. Roberts, A. R., & Yeager, K. R. (2009). Indicators of a Crisis-Prone Person. https://doi.org/10.1093/oso/9780195382907.003.0004
529. Roberts, A. R., & Yeager, K. R. (2009). Psychophysiological Reactions to a Crisis. https://doi.org/10.1093/oso/9780195382907.003.0007
530. Roberts, A. R., & Yeager, K. R. (2009). Stress Symptomatology and the General Adaptation Syndrome. https://doi.org/10.1093/oso/9780195382907.003.0008
531. Robinson, C. P., & Hocker, S. E. (2019). Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190862923.003.0098
532. Robinson, R. G. (2006). Mechanism and treatment of poststroke anxiety disorder. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544231.034
533. Robinson‐Papp, J. (2016). Autonomic Disorders. https://doi.org/10.1002/9781118621042.ch31
534. Rodas, P. A. V., & Pena, M. (2024). Prevalência da alteração de capacidade funcional, síndrome de fragilidade e sarcopenia em pacientes com mais de 60 anos atendidos na Associação Fluminense de Reabilitação. Acta Fisiátrica. https://doi.org/10.11606/issn.2317-0190.v31isupl.1a225105
535. Rodrigo, M. V. L., Oliver, A. O., Monge, M. P., Fons, V. R., & Cantalejo, Y. D. (2023). Stigma of mental illness in the gypsy ethnic group. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.1438
536. Rodriguez, C. P., Dodds, T., & Suzuki, J. (2017). Addiction. Pain Medicine. https://doi.org/10.1007/978-3-319-43133-8_33
537. Rodríguez, R. V. (2005). Aspectos clínicos de la conducta adictiva al juego: una de las adicciones no convencionales. Health and Addictions/Salud y Drogas.
538. Rodríguez, R. V. (2005). Clinical aspects of gambling: a non conventional addiction / Aspectos clínicos de la conducta adictiva al juego: una de las adicciones no convencionales. African journal of rhetoric. https://doi.org/10.21134/haaj.v5i1.122
539. Rodríguez, S. P. G., & Maestre, M. Á. M. (2006). Menopausia y trastornos psicoafectivos. Ginecología y obstetricia clínica/Ginecología y obstetricia clínica.
540. Rogers, H., & Arango‐Lasprilla, J. C. (2002). Signos y síntomas comportamentales y psicológicos más comunes en la enfermedad de Alzheimer. Suma Psicológica. https://doi.org/10.14349/sumapsi2002.225
541. Ronad, S. V., Patail, C. S., Gondbal, S. H., TC, K., Ronad, M., Pankaja, T., Badesgol, R., & Singhal, P. K. J. (2019). Professionals in metro cities suffer from anxiety disorder. Nursing & Care Open Access Journal. https://doi.org/10.15406/ncoaj.2019.06.00198
542. Roncati, L., Vadalà, M., Laurino, C., & Palmieri, B. (2020). Multiple chemical sensitivity (MCS): women’s health issue. Clinical and Experimental Obstetrics & Gynecology. https://doi.org/10.31083/j.ceog.2020.05.5127
543. Rose, E., & Weinstein, G. L. (1936). CACHEXIA HYPOPHYSEOPRIVA (SIMMOND’S DISEASE) WITH THYROID AND SUPRARENAL INSUFFICIENCY1. Endocrinology. https://doi.org/10.1210/endo-20-2-149
544. Rosen, R. C., & Nelson, C. J. (2011). Validated Questionnaires in Male Sexual Function Assessment. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-916-1_22
545. Rosen, R. C., Lane, R., & Menza, M. (1999). Effects of SSRIs on Sexual Function. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199902000-00013
546. Rotenberg, V. S. (2010). Sexual Disorders Caused by Antidepressants: Considerations in the Context of Brain Hemisphere Functions. Activitas Nervosa Superior. https://doi.org/10.1007/bf03379566
547. Rothenberger, A., & Hüther, G. (1997). [The role of psychosocial stress in childhood for structural and functional brain development:neurobiological basis of developmental psychopathology].. PubMed.
548. Rowland, D. L., & Incrocci, L. (2008). Appendix: Alphabetical Listing of DSM‐IV Sexual and Gender Identity Disorders Reviewed. https://doi.org/10.1002/9781118269978.app1
549. Rozanova, I. K., Petrovskaia, M. V., & Martynova, M. V. (2007). [Examination of personality and emotional-volitional disorders in the homeless with tuberculosis]..
550. Ruocco, A. C., & Platek, S. M. (2006). Executive function and language deficits associated with aggressive-sadistic personality. Behavioral and Brain Sciences. https://doi.org/10.1017/s0140525x06399050
551. Rure, D., Kaithwas, N., Kushwah, S. S., Mishra, N., Mishra, D. K., & Shakya, M. (2023). Psychiatric presentation in undiagnosed intracranial space-occupying lesions: A case series. Industrial Psychiatry Journal. https://doi.org/10.4103/ipj.ipj_243_23
552. Räsänen, S., Hakko, H., Herva, A., Isohanni, M., Nieminen, P., & Moring, J. (1999). Gender Differences in Long-Stay Psychiatric Inpatients. International Journal of Mental Health. https://doi.org/10.1080/00207411.1999.11449447
553. Saad, S., Shaboob, E., & Alwakeel, Z. (2020). Anesthetic Considerations in Epilepsy. Benha Journal of Applied Sciences. https://doi.org/10.21608/bjas.2020.135407
554. Saaresranta, T., Polo‐Kantola, P., & Polo, O. (2013). Practical Approach for the Diagnosis and Management of Insomnia During Menopausal Transition. Humana Press eBooks. https://doi.org/10.1007/978-1-62703-324-4_19
555. Sadzio, J., Vieker, H., Gruber, O., & Zilles‐Wegner, D. (2014). Development of Schizoaffective Psychosis in the Course of a Long-Term Occupation as Spiritual Healer: Coincidence or Causality?. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2013.13020174
556. Sahu, S., Chaudhury, S., Pathak, V., Singh, I., Mujawar, S., Arya, A., Mishra, A., Sharma, N., & Garg, G. (2021). Diverse psychiatric presentation associated with child sexual abuse. Industrial Psychiatry Journal. https://doi.org/10.4103/0972-6748.328866
557. Saint‐Jean, O., Antoine, Edy, Souid, M., & Barthélémy, F. (2004). [Concerning: aging, the beginning of dialysis, the beginning of dependence: repercussions on the psychopathology of the very old dialysis patient].. PubMed.
558. Sakakibara, R., & Katsuragawa, S. (2023). Depression and LUT (Psychogenic LUTS). https://doi.org/10.1007/978-981-99-1659-7_78
559. Salgado, C. G., & Pascua, G. Z. (2016). Síndrome de Rett. Reporte de dos casos. Acta Pediátrica Hondureña. https://doi.org/10.5377/pediatrica.v6i1.2907
560. Samico, A., & Miguel, A. S. (2019). RUDE AND AGRESSIVE COMMUNICATION BETWEEN PHYSICIANS: HOW DOES IT AFFECT US?. https://doi.org/10.26226/morressier.5d1a038257558b317a140bf9
561. Sampogna, G., Zinno, F., Giallonardo, V., Luciano, M., Vecchio, V. D., & Fiorillo, A. (2020). The de Clérambault syndrome: more than just a delusional disorder?. International Review of Psychiatry. https://doi.org/10.1080/09540261.2020.1744536
562. Sanderson, W. C., & Dublin, R. (2010). Panic Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0633
563. Sansone, R. A., & Sansone, L. A. (2010). Medically Unexplainable Somatic Symptoms: A Coat With Many Psychiatric Colors. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.09l00879gre
564. Sansone, R. A., & Sansone, L. A. (2010). SSRI-Induced Indifference.. PubMed.
565. Santini, I., Lauretis, D., Roncone, R., Tosone, A., Bianchini, D’Onofrio, S., Ortenzi, R., Giusti, L., Casacchia, M., & Pollice, R. (2014). [Psychotropic-associated sexual dysfunctions: a survey of clinical pharmacology and medication-associated practice].. PubMed. https://doi.org/10.7417/ct.2014.1728
566. Santos, C. O. D. (2017). PREVALÊNCIA DE FATORES PSICOLÓGICOS EM PACIENTES COM DISFUNÇÃO TEMPOROMANDIBULAR ATENDIDOS NA CLÍNICA ODONTOLÓGICA DA UNIVERSIDADE ESTADUAL DE FEIRA DE SANTANA.. Anais do ... Seminário de Iniciação Científica/Anais Seminário de Iniciação Científica. https://doi.org/10.13102/semic.v0i21.2498
567. Santos-Franco, J. A., Santos-Ditto, R., & Revuelta-Gutiérrez, R. (2024). Neuralgia del trigémino. Actualización en Medicina de Familia. https://doi.org/10.55783/amf.200519
568. Sardesai, A., Muneshwar, K. N., Bhardwaj, M., & Goel, D. B. (2023). The Importance of Early Diagnosis of Somatic Symptom Disorder: A Case Report. Cureus. https://doi.org/10.7759/cureus.44554
569. Sarkar, S. (2016). Psychiatric Polypharmacy, Etiology and Potential Consequences. Current Psychopharmacologye. https://doi.org/10.2174/2211556005666160916124719
570. Sarkar, S., & Dinesh, M. (2023). The threshold problem of impairment criteria in psychiatric diagnosis. Journal of SAARC Psychiatric Federation. https://doi.org/10.4103/jspf.jspf_12_23
571. Sarkar, S., Singh, S. M., Balachander, S., & Rao, P. (2014). Chronic fatigue syndrome: A review. Medical Journal of Dr D Y Patil University. https://doi.org/10.4103/0975-2870.135252
572. Sarris, A. B., Nakamura, M. C., Fernandes, L. G. R., Staichak, R. L., Pupulim, A. F., & Sobreiro, B. P. (2016). Pathophysiology, evaluation and treatment of erectile dysfunction: review article. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v95i1p18-29
573. Satpathy, S. V. (2016). Flibanserin- A Novel drug for Hypoactive Sexual Desire Disorder. International Archives of BioMedical and Clinical Research. https://doi.org/10.21276/iabcr.2016.2.1.3
574. Savitskaya, K., Sibirskaya, Y., Karachentsova, I. V., & Veprentsova, S. Y. (2024). Features of the Emotional and Personal Sphere in Adolescent Girls with Menstrual Disorders. Effective Pharmacotherapy. https://doi.org/10.33978/2307-3586-2024-20-35-33-39
575. Sayar, K. (2002). [Medically unexplained symptoms].. PubMed.
576. Scavello, I., Maseroli, E., Stasi, V. D., & Vignozzi, L. (2019). Sexual Health in Menopause. Medicina. https://doi.org/10.3390/medicina55090559
577. Scheiber-Nogueira, M.-C. (2009). Troubles sexuels et syndrome de la queue-de-cheval Sexual dysfunction in cauda equina syndrome.
578. Schenck, C. H., Lee, S., Bornemann, M. A. C., & Mahowald, M. W. (2009). Potentially Lethal Behaviors Associated With Rapid Eye Movement Sleep Behavior Disorder: Review of the Literature and Forensic Implications. Journal of Forensic Sciences. https://doi.org/10.1111/j.1556-4029.2009.01163.x
579. Scherbaum, N., & Specka, M. (2014). Komorbide psychische Störungen bei Opiatabhängigen. Suchttherapie. https://doi.org/10.1055/s-0033-1363240
580. Schildkrout, B. (2014). Delirium. https://doi.org/10.1002/9781394260447.ch2
581. Schildkrout, B. (2014). Disease #4: Alzheimer's Disease. https://doi.org/10.1002/9781394260447.ch32
582. Schildkrout, B. (2014). Disease #54: Premenstrual Dysphoric Disorder and Premenstrual Syndrome. https://doi.org/10.1002/9781394260447.ch82
583. Schildkrout, B. (2014). Vegetative Symptoms. https://doi.org/10.1002/9781394260447.ch23
584. Schlotawa, L., Adang, L., Castro, M. D., & Ahrens‐Nicklas, R. C. (2019). Multiple Sulfatase Deficiency.
585. Schmauß, M., & Pajonk, F. (2015). Agitation und Aggression in der Psychiatrie. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0041-111184
586. Schneier, F. R., Bruce, L. C., & Heimberg, R. G. (2014). Social Anxiety Disorder (Social Phobia). American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg18
587. Schoenfeld, H., Amir, V., Lichtenberg, P., & Gaulayev, B. (1990). Secondary Amenorrhea: Two Kinds of Psychogenic Disorder—A Case Report. The International Journal of Psychiatry in Medicine. https://doi.org/10.2190/1b0u-fyc8-wdfg-n6u2
588. Schut, C., Magerl, M., Hawro, T., Kupfer, J., Rose, M., Gieler, U., Maurer, M., & Peters, E. M. (2019). Disease activity and stress are linked in a subpopulation of chronic spontaneous urticaria patients. Allergy. https://doi.org/10.1111/all.14015
589. Schwager, H., & BSN, L. T. S. (2019). 09 - TREATMENT OF IATROGENIC OPIOID DEPENDANCE USING BUPERNORPHINE IN PATIENTS WITH CHRONIC PAIN A TELE-BEHAVIORAL MEDICINE PROTOCOL. https://doi.org/10.26226/morressier.5d1a038357558b317a140c62
590. Schweitzer, J. B. (2010). Attention‐Deficit/Hyperactivity Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0096
591. Seidman, S. N. (2003). Testosterone Deficiency and Mood in Aging Men: Pathogenic and Therapeutic Interactions. The World Journal of Biological Psychiatry. https://doi.org/10.3109/15622970309167905
592. Seifert, B., Lukáš, K., Charvátová, E., Vojtíšková, J., Koudelka, T., Hep, A., Bureš, J., Jirásek, V., & Dítě, P. (2007). Lower dyspeptic syndrome. Recommended diagnostic and therapeutic procedures for general practitioners 2006.
593. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
594. Sengupta, S. S., & Tasneem, H. (2023). Male sexual dysfunction: Hahnemann’s obvious cause of the modern generation. International Journal of Homoeopathic Sciences. https://doi.org/10.33545/26164485.2023.v7.i4a.956
595. Sepehrmanesh, Z., Sarmast, H., Moraveji, S. A., Sarmast, B., Mehri, Z., & Ahmadvan, A. (2020). Breast Feeding Duration and Attention Deficit Hyperactivity Disorder. Acta Scientifci Nutritional Health. https://doi.org/10.31080/asnh.2020.04.0622
596. Serrano, J. L., Vila, S., Vidal, R. C., Padilla, E. B., Lamora, N. S., Mollà, L., Rodríguez, A. M., & López, L. M. M. (2017). COMORBILIDAD ENTRE DEPRESIÓN Y CONDUCTAS IMPULSIVAS: UN CASO DE URGENCIA NEGATIVA.
597. Shahada, Z., Khalalyli, N., Allahham, L., & Kudsi, M. (2023). Acute psychosis as the presenting manifestation of lupus: case reports. International Journal of Surgery Global Health. https://doi.org/10.1097/gh9.0000000000000384
598. Shankar, B. S., Yadukul, S., & Shivakumar, B. (2014). A Case of Genital Self-mutilation Committed Before Suicide. Egyptian Journal of Forensic Sciences. https://doi.org/10.1016/j.ejfs.2014.07.004
599. Shanmugaratnam, S., Shanmugaratnam, H., & Parisaei, M. M. (2013). Premenstrual syndrome. InnovAiT Education and inspiration for general practice. https://doi.org/10.1177/1755738012467442
600. Sharabyani, S. M. (2016). MENTAL DISORDER AND THEIR TREATMENT. Journal of Fundamental and Applied Sciences. https://doi.org/10.4314/jfas.v8i3s.388
601. Sharma, V. (2021). Peripartum anxiety: parsing heterogeneity in clinical settings. Brazilian Journal of Psychiatry. https://doi.org/10.1590/1516-4446-2021-1952
602. Sharpe, M., & Wilks, D. (2002). ABC of psychological medicine: Fatigue. BMJ. https://doi.org/10.1136/bmj.325.7362.480
603. Shaughnessy, A. F. (2020). Some Drugs Slightly Improve Cognition in People with Dementia; Effects on Behavioral or Psychological Symptoms Remain Unclear.. PubMed.
604. Sheinfeld, H., Ga�l, M., Bunzel, M. E., & Vishne, T. (2007). The Etiology of Some Menstrual Disorders: A Gynecological and Psychiatric Issue. Health Care For Women International. https://doi.org/10.1080/07399330701563178
605. Shiurkute, A. (1999). [Age-related factors of psychopathology of impulse control disorders].. PubMed.
606. Silva, H. M. D., & Cardoso, L. V. (2021). RISADA PEGA: A Mnemonic Method in Portuguese for Alarm Criteria in Emergency Headaches. Deleted Journal. https://doi.org/10.48208/headachemed.2021.supplement.29
607. Silva, L. M. D., Raposo-Lima, C., Soares, C. M. G., Cerqueira, J., & Morgado, P. (2016). Koro Syndrome in an Obsessive-Compulsive Disorder Patient. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.1825
608. Silva, L. M. R. (2015). A Demência Frontal: ou o Risco da Perda do Eu e do Outro. Psicologado.
609. Silva, N. D., Singhapathirana, S., & Silva, C. E. D. (2019). Miller Fisher Syndrome presenting as unilateral abducens nerve palsy: A case report. Research Square (Research Square). https://doi.org/10.21203/rs.2.9144/v1
610. Silver, R. M., & Airoldi, J. (2016). 27. Inherited thrombophilia. CRC Press eBooks. https://doi.org/10.1201/9781315200910-28
611. Silverstein, E., Basiru, T., Aulakh, M., Verzura, M. L., & Suarez, R. (2025). Management of Acute Onset Catatonia Postpartum in a Patient With a History of Major Depressive Disorder With Psychotic Features: A Case Report. Cureus. https://doi.org/10.7759/cureus.84392
612. Siraj, Q. H. (1998). Impotence. Clinical Nuclear Medicine. https://doi.org/10.1007/978-1-4899-3356-0_34
613. Sjaastad, O., Stolt-Nielsen, A., Pareja, J. A., Fredriksen, T. A., & Vincent, M. (1999). Supraorbital Neuralgia. On the Clinical Manifestations and a Possible Therapeutic Approach. Headache The Journal of Head and Face Pain. https://doi.org/10.1046/j.1526-4610.1999.3903204.x
614. Smagula, S. F. (2014). Determinants of depressive symptom trajectories among older adults in community and treatment settings.
615. Smedick, B. C., & Wyck, D. V. (2016). Lower Extremity Compartment Syndrome From Prolonged Limb Compression and Immobilization During an Airborne Operation. Journal of Special Operations Medicine. https://doi.org/10.55460/4ez3-1j3n
616. Smith, M., Burns, D. E., & Robinson, D. (2002). Geriatric Seizures. Journal of the American Geriatrics Society. https://doi.org/10.1046/j.1532-5415.2002.50234.x
617. Snyder, S. L., Byne, W., & Lozyniak, S. (2016). Sexual Dysfunctions, Gender Dysphoria, and Paraphilic Disorders. https://doi.org/10.1002/9781118654231.ch21
618. Soares, W. B., & Lima, A. M. D. O. (2024). First Episode of Psychosis. Advances in medical technologies and clinical practice book series. https://doi.org/10.4018/979-8-3693-0851-6.ch005
619. Sommer, I. E., & Arango, C. (2017). Moving interventions from after to before diagnosis. World Psychiatry. https://doi.org/10.1002/wps.20454
620. Sommerkamp, M. E. B., Rodriguez, V. H. C., Advincula, A. L. E., Espinoza, B. X. M., & Ranilla, J. G. M. (2021). Síndrome de HaNDL y convulsiones: una presentación inusual. Facultad de Medicina.
621. Sonavane, S., Motwani, S., Karia, S., Desousa, A., & Hukumchand, A. (2023). Sexual Dysfunction with Antidepressants: A Clinical Review. Indian Journal of Private Psychiatry. https://doi.org/10.5005/jp-journals-10067-0143
622. Sousa, A. D., & Lodha, P. (2019). Sexual issues in dementia: An overview. Telangana Journal of Psychiatry. https://doi.org/10.18231/j.tjp.2019.003
623. Spiegel, E. P., & Vanderploeg, R. D. (2010). Postconcussion Syndrome. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0696
624. Stafie, C. S., & Stafie, I. I. (2019). POST COITAL ALLERGY – A CASE REPORT OF POST ORGASMIC ILLNESS SYNDROME. The Medical-Surgical Journal.
625. Staniloiu, A., Borsutzky, S., & Markowitsch, H. J. (2010). P01-315 - Dissociative Memory Impairments and Immigration. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70523-x
626. Steenkamp, M. M., & Litz, B. T. (2013). Early Interventions with Military Personnel. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780199928262.003.0052
627. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
628. Steinberg, D. (1987). Basic adolescent psychiatry.
629. Steineck, G., Bergmark, K., Henningsohn, L., al‐Abany, M., Dickman, P. W., & Helgason, Á. R. (2002). Symptom Documentation in Cancer Survivors as a Basis for Therapy Modifications. Acta Oncologica. https://doi.org/10.1080/02841860260088782
630. Steiner, M., Pearlstein, T., Cohen, L. S., Endicott, J., Kornstein, S. G., Roberts, C. P., Roberts, D. L., & Yonkers, K. A. (2006). Expert Guidelines for the Treatment of Severe PMS, PMDD, and Comorbidities: The Role of SSRIs. Journal of Women s Health. https://doi.org/10.1089/jwh.2006.15.57
631. Sterner, Y., & Gerdle, B. (2004). Acute and chronic whiplash disorders - a review. Journal of Rehabilitation Medicine. https://doi.org/10.1080/16501970410030742
632. Stiefel, F., Bourquin, C., & Saraga, M. (2019). [A relationship under the influence : collusive phenomena in clinics].. PubMed.
633. Stone, M. H. (2010). Sexual Sadism: A Portrait of Evil. Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry. https://doi.org/10.1521/jaap.2010.38.1.133
634. Stringer, J. D. (2016). Gender and Sexual Health: Sexual Dysfunction.. PubMed.
635. Stuparu, C. (2020). Female orgasm disorder. Anorgasmia. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2020.13.25
636. Summers, C. B. (2007). Cognitive-Behavior Group Therapy in Residential Treatment. https://doi.org/10.4324/9780203941157-16
637. Sundal, C., & Wszołek, Z. K. (2017). CSF1R- Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.
638. Sutton, F., Bârcă, D., Komoltsev, I., Craiu, D., Guekht, A., Oertzen, T. J. V., & Cock, H. R. (2020). Testing blood and CSF in people with epilepsy: a practical guide. Epileptic Disorders. https://doi.org/10.1684/epd.2020.1191
639. Szkodny, L. E., Jacobson, N. C., Llera, S. J., & Newman, M. G. (2014). Generalized Anxiety Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg19
640. Tait, G. (2006). A disordered approach. Office of Education Research; Faculty of Education.
641. Tang‐Wai, D. F., Josephs, K. A., & Petersen, R. C. (2005). Alzheimer's disease: overview. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.029
642. Teasell, R., & Finestone, H. M. (1999). Socioeconomic Factors and Work Disability: Clues to Managing Chronic Pain Disorder. Pain Research and Management. https://doi.org/10.1155/1999/168470
643. Teran, A., Robert, B., Greenblatt, Barfield, W. E., & Bohler, C. S. (1987). Premenstrual syndrome: What it is and what it is not. Stress Medicine. https://doi.org/10.1002/smi.2460030308
644. Teunissen, D., Wong, S. H. L. F., & Lagro-Janssen, A. L. M. (2016). [Recognizing signs of sexual abuse].. PubMed.
645. Thase, M. E., & Lang, S. S. (2004). Dysthymia and Aging. https://doi.org/10.1093/oso/9780195159189.003.0013
646. Thomas, J., Blanken, A. E., Huang, A. J., Maguen, S., Gibson, C. J., & Sumner, J. A. (2024). Dimensions of posttraumatic stress disorder and menopause-related health in midlife women veterans. Menopause The Journal of The North American Menopause Society. https://doi.org/10.1097/gme.0000000000002410
647. Thompson, T. R., & McDonald, W. M. (2002). The Assessment of Depressive States. https://doi.org/10.1002/0470846410.ch29
648. Todorović, S. (2016). Socijalno medicinske karakteristike i razlike između alkoholičara sa periodičnim i kontinuiranim pijenjem / Social and Medical Characteristics and Differences Between Alcoholics With Periodic and Continuous Drinking. SESTRINSKI ŽURNAL. https://doi.org/10.7251/sez0116005t
649. Tollefson, G. D., Souêtre, E., Thomander, L., & Potvin, J. H. (1993). Comorbid anxious signs and symptoms in major depression. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199300840-00013
650. Tomljanović, M. (2018). Tajne dugovječnosti sadomazohističkih odnosa.
651. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
652. Torre, A. L., Conca, A., Duffy, D., Giupponi, G., Pompili, M., & Grözinger, M. (2013). Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review Part II: Antipsychotics. Pharmacopsychiatry. https://doi.org/10.1055/s-0033-1347177
653. Trahan, M. A., Kahng, S., Donaldson, J. M., & McNabney, M. (2013). “Just Make it Stop”: A Case Report of Excessive Crying in an Individual with Dementia. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.12339
654. Tran, F., Bichai, G. H., Kravetz, Z., & Meriden, Z. (2025). Management of Antidepressant-Induced Sexual Dysfunction: A Literature Review. Cureus. https://doi.org/10.7759/cureus.90170
655. Tuncer, S. K. (2023). Menopoz Döneminde Egzersiz. Özgür Yayınları eBooks. https://doi.org/10.58830/ozgur.pub386.c1639
656. Turkan, S., Kara, E., İlhan, R. S., Şahiner, Ş. Y., & Saka, M. C. (2024). Menstrual Psychosis with Premenstrual Onset: A case presentation. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1544
657. Ueda, S., Marutani, T., & Okubo, Y. (2013). [Cenesthopathy in the presenium associated with manic factor resolved with lithium carbonate: two female cases with underlying manic or mixed state].. PubMed.
658. Unknown (2019). Female Sexual Dysfunction. Obstetrics and Gynecology. https://doi.org/10.1097/aog.0000000000003324
659. Unknown (2019). Female Sexual Dysfunction. Obstetrics and Gynecology. https://doi.org/10.1097/aog.0000000000003325
660. Unknown (2019). Kleine-Levin Syndrome. Definitions. https://doi.org/10.32388/414343
661. Unknown (2019). Late-Onset Manic Episode after Bariatric Surgery. International Journal of Psychiatry. https://doi.org/10.33140/ijp.04.01.6
662. Unknown (2019). Premenstrual Syndrome (PMS): An Enigma. Journal of Gynecology & Reproductive Medicine. https://doi.org/10.33140/jgrm.03.05.03
663. Unknown (2019). Sexual Sadism Disorder- short review. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.11.134
664. Uppal, T., Amarasekara, C., & Kaushik, V. (2011). Chronic pelvic pain. Australasian Journal of Ultrasound in Medicine. https://doi.org/10.1002/j.2205-0140.2011.tb00182.x
665. Usman, S. B., Indusekhar, R., & O’Brien, S. (2007). Hormonal management of premenstrual syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology. https://doi.org/10.1016/j.bpobgyn.2007.07.001
666. Utian, W. H. (2005). Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review. Health and Quality of Life Outcomes. https://doi.org/10.1186/1477-7525-3-47
667. Vale, T. C., Pedroso, J. L., Knobel, M., & Knobel, E. (2016). Late-Onset Psychogenic Chronic Phonic-Tics. Tremor and Other Hyperkinetic Movements. https://doi.org/10.5334/tohm.299
668. Vanderschuren, L. J. M. J. (2008). Neurobehavioral Mechanisms of Compulsive Drug Seeking. https://doi.org/10.1093/oso/9780195300550.003.0009
669. Veeninga, A. T., & Kraaimaat, F. W. (1995). A multifactorial approach to complaints during the climacteric. Journal of Reproductive and Infant Psychology. https://doi.org/10.1080/02646839508403237
670. Verma, S., & Agrawal, R. (2021). The lasting effects of childhood trauma. Current psychiatry. https://doi.org/10.12788/cp.0101
671. Vicente, J. F. M. (2014). Estado epiléptico refractario en el entorno de la terapia intensiva. Medicina Crítica.
672. Vicente, S. B., Tavares, M. B., & Siqueira, E. C. D. (2023). Síndrome de Tourette. Revista Eletrônica Acervo Médico. https://doi.org/10.25248/reamed.e12923.2023
673. Vijayakumar, K., Vishwajit, G. V., Jeyaprakash, J., & Shanmugiah, A. (2024). Les Psychoses Passionnelles: A Rare Case Report of Multiple Erotomanic Delusions in a Male. Annals of Indian Psychiatry. https://doi.org/10.4103/aip.aip_136_24
674. Vilibić, M., Jukić, V., Vidović, A., & Brečić, P. (2013). Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report.. PubMed.
675. Viljoen, M. F. (2015). Sleep tips for insomnia patients. Mental Health Matters.
676. Villamar, S., & Lorena, J. (2019). Factores psicosociales y depresión geriátrica en un paciente.
677. Villarroya, B. G., Voicu, A., Catalán, P. T., & Lopez, P. (2021). La soledad en el anciano, presentación de un caso clínico. Revista Sanitaria de Investigación.
678. Voermans, N. C., Visser, M. D., Wokke, J. H. J., & Brusse, E. (2013). [Increased CK activity in serum without symptoms: further investigations often unnecessary].. PubMed.
679. Volpe‐Gillot, L. (2007). Troubles cognitifs, démence et épilepsie. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2007.0097
680. Wahyuni, A. A. S., WIGUNA, I. G. R. P., & Aditya, M. R. (2023). WAHAM SOMATIK : SEBUAH TINJAUAN PUSTAKA. Jurnal Hasil Penelitian dan Pengembangan (JHPP). https://doi.org/10.61116/jhpp.v1i3.156
681. Wahyuni, A., & Fr, C. (2020). Gangguan Mental Organik e.c. Epilepsi pada Laki-Laki Usia 17 Tahun : Laporan Kasus. Jurnal Medula.
682. Wakefield, J. C., & Schmitz, M. F. (2014). Uncomplicated depression is normal sadness, not depressive disorder: further evidence from the NESARC. World Psychiatry. https://doi.org/10.1002/wps.20155
683. Wakil, L., Meltzer‐Brody, S., & Girdler, S. S. (2012). Premenstrual Dysphoric Disorder: How to Alleviate Her Suffering; Accurate Diagnosis, Tailored Treatments Can Greatly Improve Women's Quality of Life. Current psychiatry.
684. Walther, M., & Woods, D. W. (2010). Trichotillomania. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1011
685. Ward, R., & Manchip, S. (2012). ‘Inappropriate’ sexual behaviours in dementia. Reviews in Clinical Gerontology. https://doi.org/10.1017/s0959259812000196
686. Weber, P., Vepřeková, B., & Kadaňka, Z. (2009). Psychiatrická problematika v intenzivní medicíně vyššího věku.
687. Welte-Santana, C., Nunes, F. T., Toledo, L. C. D., & Oliveira, L. P. (2016). Significant weight loss related to Briquet syndrome: A case report. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.2084
688. Westby, A., & Coburn-Pierce, M. (2018). Autism spectrum disorder in primary care. The Nurse Practitioner. https://doi.org/10.1097/01.npr.0000530326.85465.8b
689. Wettstein, R. M., & Kelly, J. (2016). A PHARMACOLOGICAL APPROACH TO SEXUALLY DEVIANT BEHAVIOR IN THE COMMUNITY.
690. Wick, J. Y., & Zanni, G. R. (2005). Disinhibition: Clinical Challenges in the Long-Term Care Facility. The Consultant Pharmacist. https://doi.org/10.4140/tcp.n.2005.1006
691. Wilson, B. (1991). The Effect of Drugs on Male Sexual Function and Fertility. The Nurse Practitioner. https://doi.org/10.1097/00006205-199109000-00009
692. Winner, J. G. (2012). Overwhelmed by Side Effects. Current psychiatry.
693. Winter, A., & Buhlmann, U. (2013). Spieglein, Spieglein an der Wand … Klinische Charakteristika der körperdysmorphen Störung. Zeitschrift für Psychiatrie Psychologie und Psychotherapie. https://doi.org/10.1024/1661-4747/a000155
694. Woo, C. H., & Kim, S. (2014). Effectiveness of the Military Mental Health Promotion Program. Journal of Korean Academy of Nursing. https://doi.org/10.4040/jkan.2014.44.6.717
695. Wood, G. W. (2006). Intramedullary nailing of femoral and tibial shaft fractures. Journal of Orthopaedic Science. https://doi.org/10.1007/s00776-006-1061-6
696. Wooldridge, J. S. (2012). GENDER DIFFERENCES IN COPING AND PHYSICAL AND MENTAL HEALTH OUTCOMES AMONG OLDER ADULTS WITH OSTEOARTHRITIS.
697. Wróbel, M. R., & Mosiołek, A. (2018). Dysfunkcje seksualne w przebiegu zaburzeń depresyjnych.
698. Wylie, K., & Hallam-Jones, R. (2009). Inhibited Arousal in Women. Journal of Family Psychotherapy. https://doi.org/10.1080/08975350902969966
699. Xiao, J., Chan, C. W., & Chow, K. M. (2019). LIVING WITH DIGNITY AMONG CHINESE CANCER PATIENTS UNDERGOING CHEMOTHERAPY: A QUALITATIVE STUDY. https://doi.org/10.26226/morressier.5cdbe0ab618793e647b12cfb
700. Yadav, P., Chauhan, V. S., Goyal, S., & Khan, S. (2016). Two cases of male genital self-mutilation. Industrial Psychiatry Journal. https://doi.org/10.4103/0972-6748.207854
701. Yagubov, М. A., & Mihalev, M. (2015). Sexual dysfunction in men with depressive disorders. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro201511541108-112
702. Yama, K., Shinbo, H., Machida, M., & Miura, J. (2018). The plasma level of 8-hydroxy-2'-deoxyguanosine in relation to menstruation. Proceedings for Annual Meeting of The Japanese Pharmacological Society. https://doi.org/10.1254/jpssuppl.wcp2018.0_po4-3-20
703. Yetkın, S., & Çor, S. A. (2023). Psychological Inflexibility in Depression with Psychotic Features: A Case Report. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.2180
704. Young, P. (2019). Síndrome de Diógenes. Fronteras en Medicina. https://doi.org/10.31954/rfem/201904/0199-0202
705. Yüksel, Y., Onultan, O., & Berber, M. (2008). Nonconvulsive status epilepticus during childhood: clinical and electroencephalographic features.. PubMed.
706. Zisook, S., Reynolds, C. F., Pies, R. W., Simon, N. M., Lebowitz, B. D., Madowitz, J., Tal-Young, I., & Shear, M. K. (2010). Bereavement, Complicated Grief, and DSM, Part 1: Depression. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.10ac06303blu
707. Zięba, A. A., Dudek, D., Jawor, M., & Krzysiek, J. (1999). [Sexual dysfunctions in depressed patients].. PubMed.
708. Zoellner, L. A., Graham, B., & Bedard‐Gilligan, M. (2019). Trauma- and Stressor-Related Disorders. Routledge eBooks. https://doi.org/10.4324/9780429028267-10
709. Zulkifli, N., Khuzaini, A. M., Aziz, A. A., & Awang, H. (2023). Trauma-related hallucination in an 8-year-old child with dissociative symptoms. Deleted Journal. https://doi.org/10.4103/mjp.mjp_10_23
710. Zutshi, A., Math, S. B., & Reddy, Y. C. J. (2007). Escitalopram in Obsessive-Compulsive Disorder. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611c
711. Çelik, A. S., & Pasinlioğlu, T. (2013). KLİMAKTERİK DÖNEMDE YAŞANAN SEMPTOMLAR VE HEMŞİRENİN ROLÜ.
712. Çoban, A., Özyurt, S., Meriç, K., Mısırlı, H., Tüzün, E., & Türkoğlu, R. (2016). Limbic Encephalitis Associated with Sjögren's Syndrome: Report of Three Cases. Internal Medicine. https://doi.org/10.2169/internalmedicine.55.6222
713. Østensen, M. (2018). SP0046 What we need to consider in physician-patient communication on sexual problems in different rheumatic conditions. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2018-eular.7832
714. Ünsal, M. A., & Doğan, T. (2020). Is It Really Rare? Restless Genital Syndrome. Nöro Psikiyatri Arşivi. https://doi.org/10.29399/npa.24950
715. Žukov, I., Ptáček, R., Raboch, J., Domluvilová, D., Kuželová, H., Fischer, S., & Kozelek, P. (2010). Premenstrual dysphoric disorder--review of actual findings about mental disorders related to menstrual cycle and possibilities of their therapy.. PubMed.
716. Коcharyan, G. (2021). Prevalence of Diminished Libido and Hypoactive Sexual Desire Disorder. Health of Man. https://doi.org/10.30841/2307-5090.4.2021.252399